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Abstract 
Within the general public, nicotine is commonly thought of as a harmful molecule 
due to its role in tobacco addiction. However, nicotinic stimulation of the cholinergic system 
has also been shown to enhance cognitive functioning. This enhancement is thought to be 
caused by an increase in the release of the neurotransmitter, acetylcholine (ACh), which is 
responsible for mediating a variety of cognitive processes, such as REM sleep and memory 
formation. Recent research by Melichercik and colleagues shows that systemic nicotine 
administration enhances memory acquisition for both object location and object recognition 
memory in rats, as assessed by a modified version of the novel object recognition test (NOR). 
Using a standard NOR test we were able to reproduce their behavioral results: systemic 
nicotine administration enhances object recognition memory acquisition. Furthermore, we 
show for the first time that these behavioral results can be correlated with an increase in 
neuronal activation in the medial septum using immunohistochemical techniques. This 
research has implications for understanding the pathology that underlies neurodegenerative 
disorders with cholinergic involvement such as Alzheimer’s Disease. 
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An introduction to smoking, nicotine, acetylcholine, learning and memory 
Smoking 
People who start smoking during adolescence account for the largest proportion of 
people who struggle with addiction to cigarettes (Shram, 2007). Due to the copious amounts 
of carcinogenic substances found in tobacco, it is estimated that smoking-related deaths will 
be the leading cause of fatality worldwide by 2015. In addition to these carcinogenic 
substances, tobacco also contains nicotine. While the general public usually only hears about 
the addictive nature of smoking and the carcinogenic effects associated with tobacco use, 
neuroscientists believe that nicotine may actually facilitate memory formation through the 
activation of nicotinic acetylcholine receptors.  
 
Acetylcholine, a Brief Overview 
Acetylcholine (ACh) is responsible for all muscle movement, plays a role in REM 
sleep, and is essential for facilitating perpetual learning (Shiromani, 1987 and Yakel, 2012). 
Once released, ACh is able to activate nicotinic and muscarinic acetylcholine receptors 
(nAChR and mAChR). There are several subcategories of nAChRs and mAChRs spread 
throughout the brain (Howes, 2009). The main difference between the two categories is that 
nAChRs are ionotropic, whereas mAChR are metabotropic (Fisher, 2008).  Both nAChRs 
and mAChR are commonly found on the surface of neuronal cells. One way that nAChRs are 
able to alter cellular activity is by modifying the electropotential gradient present between the 
inside environment of the neuron and the extracellular matrix. The binding of ACh to 
nAChRs causes ligand gated ion channels located in the cell membrane to open, allowing 
positively charged calcium ions to diffuse into the negatively charged environment of the 
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neuron. This influx of positive ions causes a brief depolarization across the cell membrane 
which is propagated and eventually causes the release of  neurotransmitter into the synaptic 
cleft. ACh is degraded by the enzyme acetylcholinesterase shortly after activating the 
cholinergic receptor. Once ACh is no longer bound to the receptor, the calcium ion channels 
close and repolarization begins. 
 
Nicotinic Acetylcholine Receptors (nAChRs)  
All neuronal nAChRs found in the CNS are pentameric, meaning they are composed 
of 5 subunits (Figure 1). These five subunits are arranged in a symmetric fashion around a 
central ion pore (Decker, 2000). According to genetic studies, there are at least 11 unique 
subunits that can combine to make a pentameric nAChR. Eight of these subunits have been 
designated as α-subunits (α2-α9), and three have been designated as β-subunits (β2-β4). 
Each subunit contains a N-terminal hydrophilic domain, a variable C-terminal domain 
located in the cytoplasm that is capable of being phosphorylated, and four transmembrane 
domains designated M1-M4 (Changeux, 1998). 
 Two main subtypes of neuronal nAChRs involved in cognitive processes are the 
heteropentameric α4β2, and homopentameric α7 receptors. The α4β2 receptor can either 
assume a (α4)3(β2)2 or (α4)2(β2)3 stoichiometry, while the α7 receptor exists only as the 
(α7)5 configuration. Both α7 and α4β2 subtypes are located pre and postsynaptically within 
hippocampal neurons, suggesting they play a critical role in modifying synaptic transmission 
and neurotransmitter release (Kenny, 2008). Severe spatial memory impairments can be seen 
upon using an antisense knockdown of the α7 nicotinic receptor in rats, indicating that the α7 
receptor is crucial for spatial memory processes (Cruzon, 2006).  Administration of the α4β2 
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receptor agonist, RJR 2403, has been shown to significantly improve working memory, 
indicating a role for the α4β2 receptor in working memory (Levin, 2002). Research also 
shows that activation of α7 and α4 nAChRs can help limit neuronal apoptosis by preventing 
glutamate-induced excitotoxicity, a common problem in several neurodegenerative disorders 
(Akaike, 2010). 
 
Muscarinic Acetylcholine Receptors (mAChRs) 
Acetylcholine is also able to activate muscarinic acetylcholine receptors (mAChRs) in 
the CNS. Like nAChRs, mAChRs are also composed of 5 subunits, M1-M5. All mAChRs are 
metabotropic, class I heptahelical G-protein-coupled receptors (Figure 2). Upon activation, 
mAChRs regulate second messengers and ion channel activation through G-protein binding 
(Caulfield, 1998). In addition to the normal agonist-binding site, mAChRs activity can be 
modified through allosteric binding of other molecules (Cristopoulos, 1998). 
M1 mAChRs are located both pre and post synaptically in the PNS and CNS (Ito, 
2009). They are present throughout the cerebral cortex and hippocampus, areas that are 
involved in learning and memory processes. Current research shows that selective M1 
receptor agonism may be a useful therapeutic approach for treating Alzheimer’s disease 
(Fisher, 2008).  M2 mAChRs are also widely expressed in the PNS and CNS. M2 receptors 
are the most prevalent mAChR subtype in the thalamus, hypothalamus, midbrain, caudate 
putamen, and cerebellum. Selective activation of M2 receptors in the putamen inhibits the 
release of dopamine, a feature that may one day lead to a treatment option for schizophrenia 
(Oki, 2005). A large number of M2 receptors are also found in myocardial and smooth muscle 
tissue. M3 receptors are involved in respiratory and gastrointestinal functioning in the PNS. 
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While they are also located throughout the CNS, they are present in much lower 
concentrations than their M1 and M2 relatives. Due to their relatively low concentration, the 
role of these receptors in the CNS is still largely unknown (Eglen, 2006). The role of M4 
mAChRs in the CNS is somewhat unknown as well. The majority of M4 receptors can be 
found in the corpus striatum where they co-localize with dopamine receptors. Recent 
research indicates that M4 receptors help mediate the antipsychotic effects of xanomeline, a 
drug currently being developed to treat schizophrenia (Dencker, 2011). The M5 receptor is 
the only muscarinic receptor to be expressed in the substantia nigra, the primary location of 
dopaminergic cells; and activation of the M5 receptor has been shown to facilitate dopamine 
release (Eglen, 2006). M5 receptor activation is also thought to facilitate cognitive processes 
due to its ability to dilate cerebral blood vessels. Genetically modified M5 knockout mice  
exhibit a significant decrease in cerebral blood vessel dilation, a common occurrence in AD 
and focal ischemia. Therefore, selective activation of the M5 receptor may represent an 
attractive target for novel drug therapies (Yamada, 2001).  
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Figure 1: Heteropentameric α4β2 and homopentameric α7 nicotinic acetylcholine receptors 




Figure 2: Representative muscarinic acetylcholine receptor (mAChR) and associated ACh 
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Nicotinic Activation of the Cholinergic System 
Nicotinic activation of nAChRs results in the same mechanism of depolarization 
across the cell membrane as ACh. In addition to mimicking the effects of ACh at 
postsynaptic nAChRs, activation of presynaptic nAChRs by nicotine stimulates the release of 
ACh itself, resulting in an increase of neuronal activity. Unlike ACh, nicotine is not degraded 
by acetylcholinesterase. This means that when nicotine is bound to a nAChR, the ligand 
gated ion channel is able to remain open for a longer period of time, resulting in an extended 
period of depolarization (Carlson, 2010). Repeated administration of nicotine appears to 
cause a desensitization of nAChR functioning; however, this desensitization does not reduce 
nicotine’s ability to facilitate memory formation (Gould, 2009). Therefore, other receptors 
must also be involved in nicotine’s memory enhancing abilities. One hypothesis is that 
nicotine may also elicit a secondary effect through activation of mAChRs. A recent two-part 
study determined that one form of memory, spatial memory, improved with nicotine 
administration. However, when mAChR activity was blocked using chemical inhibitors, 
nicotine administration did not enhance spatial memory, implementing nicotinic activation of 
mAChRs in spatial memory processes (Liu, 2004).  
 
Long Term Potentiation (LTP) 
Synaptic plasticity is the constant rewiring of neuronal circuitry that serves as the 
basis for memory formation. The connections between neurons are strengthened, by making 
them more likely to be activated together in the future, when they are subject increased levels 
of stimulation, in a process known as long term potentiation (LTP). LTP was first observed 
in human hippocampal cells in 1973 (Bliss, 1993).  Acetylcholine is known to be one of 
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many biological factors that affects LTP. Cholinergic receptors are commonly found on the 
surface of neuronal cells. One mechanism through which these receptors function is by 
modifying the electropotential gradient present between the inside environment of the neuron 
and the extracellular matrix. Upon stimulation from ACh, cholinergic receptors cause ligand 
gated ion channels located in the cell membrane to open, allowing for the diffusion of 
positively charged calcium ions into the negatively charged environment of the neuron, 
causing a brief depolarization across the cell membrane. Shortly after activating the 
cholinergic receptor, Ach is degraded by the enzyme acetylcholinesterase,  causing ion 
channels to close and therefore cessation of the flow of calcium ions into the cell. Activation 
of nAChRs by nicotine causes the same mechanism of depolarization across the cell 
membrane. However, nicotine is not degraded by acetylcholinesterase, which allows the 
ligand gated ion channel to remain open for a longer period of time, resulting in an extended 
period of depolarization (Carlson, 2010). Repeated nAChR activation resulting in LTP is 
thought to be a major way in which high levels of ACh facilitate encoding (Radcliffe, 1999). 
Research has shown that the acquisition of new memories happens within 48 hours, making 
memory formation a relatively quick process (Tse 2007).  
  
Types of Memory 
Ever since researchers first attempted to propose a mechanism that would describe 
how memory formation occurs, no one has been able to create a unanimously agreed upon 
and complete model. Early hypotheses about how brain structure affects memory function 
were guided by the observations made by neurologists and neuropsychologists as they 
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worked with patients who had suffered various forms of brain damage. The most famous 
example of how brain structure is related to function comes from the case of Henry Gustav 
Molaison, long known as H.M. In the 1950’s, H.M. underwent a bilateral medial temporal 
lobectomy, removing his hippocampus in an attempt to cure his epileptic seizures. As a result 
of the procedure, H.M. displayed severe anterograde amnesia, implicating hippocampal 
involvement in memory formation. Because some forms of his memory were left intact, such 
as information pertaining to his childhood, H.M.’s case also demonstrated that memory exists 
in multiple unique forms and that particular brain areas are responsible for certain forms of 
memory. For over 50 years, Wilder Penfield and Brenda Milner continued to study the 
effects of the lobectomy on H.M.’s behavior, making him one of the first cases used to create 
the field of cognitive neuropsychology. Currently, neuropsychology is one of the fastest 
growing fields as it attempts to understand how brain structure is related to function. 
 
The Three Stage Model 
In 1962, psychologists Richard Atkinson and Richard Shiffrin proposed The Three 
Stage Model of Memory, which would eventually become the most commonly accepted 
psychological model used to describe the basic mechanism underlying memory formation 
(Figure 3). The first stage of the model describes how incoming information is dealt with. 
First, sensory information about the outside world is collected. After being collected, the 
information is encoded and sent to the sensory store. The sensory store is often referred to as 
a multimodal storage system because it deals with both visual and auditory information. The 
encoding of visual information results in iconic memory formation, while the encoding of 
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auditory information becomes echoic memory. The sensory memory store has a relatively 
small capacity and is only able to retain information for about half a second. If the brain 
actively pays attention to one of these incoming streams of information, the information is 
transferred to the second stage, short-term storage. However, if attention is not directed 
towards the incoming streams, the information decays and is forgotten.   
Short-term storage has a smaller capacity than the sensory store and is limited to 
around 7+/- 2 chunks of information. Information can be stored in short-term storage for up 
to 18 seconds (Milner, 1956). Just as with the sensory store, if information contained in 
short-term storage is ignored, it will decay and be forgotten. If the information in the short-
term store is further rehearsed through active thought processes, it has the opportunity to be 
transferred into the final compartment, long-term memory. Theoretically, information 
transferred to long-term memory should remain indefinitely. This being said, the Atkinson-
Shiffrin model also states that information is susceptible to degradation over time, or 
corruption through interference, the process by which new information replaces existing 
information (Gazzaniga, 2009).   
The Three Stage Model of Memory is often criticized for being too linear and 
simplistic because it does not take into account the various subdivisions of short-term 
memory and long-term memory, or incorporate working memory. While more recent models 
of memory formation still contain the basics of the three-stage model, they focus more on 
functioning of working memory. In current models of memory formation, short-term 
memory refers to small amounts information that are held passively and are later able to be 
reproduced without any manipulation, such as a repeating a phone number back to someone 
(Swanson, 2007). 
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Working Memory 
Dissatisfied with the description of the short-term store in the Atkinson-Shiffrin 
three-stage model of memory, Alan Baddeley and Graham Hitch proposed a new model of 
working memory (WM) in 1974. Their model proposed that WM is responsible for not only 
the temporary storage, but also the manipulation of information needed for complex 
cognitive processes including both verbal and non-verbal tasks. Working memory receives 
input from both long-term memory and short-term stores. Their model initially divided WM 
into three individual components: the central executive, visuospatial sketchpad, and 
phonological loop (Figure 4) (Baddeley, 1992). Eventually, a fourth component known as 
the episodic buffer, was added to the model to account for phenomena that could not be 
represented within the initial model (Baddeley, 2000). Within this model, the central 
executive acts as a manager, controlling the flow of information to and from the visuospatial 
sketchpad and phonological loop. The visuospatial sketchpad is responsible for the storage 
and manipulation of visuospatial information, while the phonological loop is responsible for 
the storage and manipulation of auditory information. Because visual and verbal memory 
tasks can be performed simultaneously with minimal interference, the sketchpad and loop are 
believed to operate totally independently of each other (Cocchini, 2002). PET imaging 
studies provide further evidence for the physical separation of verbal and spatial processing 
as verbal tasks only produce increased neuronal activity in left hemispherical regions, while 
spatial tasks only produce increased neuronal activity in right-hemispherical regions (Smith, 
1996). 
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The Phonological Loop 
The phonological loop is responsible for the storage and manipulation of auditory 
information and can be further divided into of two parts: the phonological store and 
articulatory loop. The phonological store is responsible for temporarily holding information 
while the articulatory loop continuously rehearses it in order to prevent the inherently rapid 
decay of information from the store.  
The phonological loop is composed of neuronal network located in the left lateral 
frontal and inferior parietal lobes. This is verified by several case studies in which 
participants who have sustained injury to the left inferior parietal lobe exhibit phonological 
working memory deficits as well as reduced capacity for auditory information (Gazzaniga, 
2009). Likewise, damage to the left hemispherical portion of premotor cortex, supplementary 
motor cortex, or Broca’s area results in impaired phonological rehearsal function 
(Gathercole, 1999) .  
One of the more important roles that the phonological loop assumes is storing 
auditory information about unfamiliar words while they are being committed to memory 
(Baddeley, 1998a). By demonstrating that participants have a more difficult time 
remembering sequences of similar sounding letters such as B, C, D, G, T, than sequences of 
letters that had distinct sounds such as F, Y, W, R, T, it was determined that the phonological 
loop encodes incoming information acoustically as opposed to visually. Studies also show 
that working memory is encoded acoustically rather than semantically because participants 
have an easier time recalling a list of dissimilar sounding, unrelated words, than a list of 
related, similar sounding words (Gazzaniga, 2009). 
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The Visuospatial Sketchpad 
Analogous to how the phonological loop is responsible for the temporary storage and 
manipulation of auditory information, the visuospatial sketchpad is responsible for the 
temporary storage and manipulation of visuospatial information. The sketchpad is 
responsible for visual orientated tasks such as creating a virtual map of one’s environment, 
optical memory recall, and mental calculations. Unlike the phonological loop, the 
components of the sketchpad are not fully understood; however, it is thought to have separate 
visual, spatial/sequential, and kinesthetic components (Baddeley, 2003). 
The Central Executive 
The central executive acts as the primary control mechanism and relay center for 
working memory. It is often thought of as a homunculus, a term used in psychology to 
describe a “little man” who makes executive decisions. It is able to direct attention by 
selectively focusing on or ignoring incoming information. Unlike the phonological loop and 
visuospatial sketchpad, the central executive does not have a singular modality. This 
multimodality allows for the exchange of information between the sketchpad, loop, as and 
long term memory (Baddeley, 1998b). 
The Episodic Buffer 
Some of the initial inspiration to rethink the original model of working memory came 
from case studies of highly intelligent but densely amnesic patients. While these amnesic 
patients were unable to encode new information and transfer it to long-term memory, they 
still had the ability to recall recent stories. These stories were much too long to be held only 
in the phonological loop, therefore another storage system was needed. In order to account 
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for phenomena like these that could not be represented in the original model of working 
memory, Baddeley introduced a new component, the episodic buffer. The episodic buffer 
was added in order to act as a temporary, multimodal storage space capable of 
chronologically integrating auditory and visual information with information stored in long 
term memory, in order to create a kind of cognitive movie (Baddeley, 2002).  
The episodic buffer is also thought to be involved with chunking, the process by 
which prior knowledge is repackaged in a more efficient manor thereby increasing the 
capacity of working memory. Due to its wide range of abilities and functions, it is unlikely 
that the episodic buffer is contained in a single anatomical location (Baddeley, 2003).  
Long-Term Memory 
Long-term memory (LTM) has an exponentially larger capacity for information than 
both working and sensory memory, and is theoretically able to retain it indefinitely. 
Information stored in LTM can be further distinguished as either declarative or implicit 
memory. Declarative memory encompasses all conscious information that can be recalled 
such as general knowledge. Implicit memory, which is often referred to as procedural 
memory, includes all unconsciously recalled information such as learned skills like riding a 
bicycle (Gazzaniga, 2009) 
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Declarative Memory  
Declarative memory encompasses all the information we are consciously able to 
recall, such as events facts. FMRI studies show that prefrontal and medial temporal areas, 
especially the hippocampus and perirhinal cortex, are involved in declarative memory 
formation and retrieval processes. During the formation of declarative memories, the 
hippocampus receives information from multiple brain regions including the sensory and 
motor association cortex, the basal ganglia and the amygdala. The hippocampus is able to 
form associations between various information inputs during the consolidation process, 
allowing us to remember relationships such as how something tasted and where we were 
when we tasted it (Carlson, 2008). Studies show that information is constantly sent back and 
forth between working and declarative memory. Since the prefrontal cortex is partially 
responsible for the selection and organization of information entering working memory, it 
may be indirectly involved in declarative memory formation (Weis, 2004).  
Declarative memory can be further distinguished as either episodic or semantic 
memory. Episodic memory pertains to the time and place where personal events occurred, 
such as remembering when and where your 16th birthday party was held. Conversely, 
semantic memories contain information unrelated to one’s personal life such as facts learned 
in school. However, these two types of memory are not mutually exclusive. They are 
combined when forming autobiographical memories; complex combinations of episodic and 
semantic memories about the events of one’s life (Purves, 2007). For example, a piece of 
semantic information may be that Connecticut College is located in New London, CT. A 
student who attended Conn will have his own episodic memories about his time there which 
will in turn help to reconstruct his semantic knowledge of the campus. 
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Implicit Memory 
The other branch of LTM, implicit memory, accounts for learned information below 
the level of consciousness, and is able to be accessed without conscious control or attention. 
Implicit memory is named so because it is clinically assessed using implicit tests; tests in 
which memory is not directly assessed but rather inferred from behavior. Unlike declarative 
memory, acquiring implicit information does not require deliberate, active, memorization. 
The first evidence that there were multiple forms of LTM arose from the study of patients 
with damage to the medial temporal region. As demonstrated by H.M. and others, damage to 
the medial temporal region results in the inability to recall past events and information while 
leaving skill based learning tasks intact. Implicit memory can be further subdivided into three 
categories: procedural memory, classical conditioning, and priming (Carlson, 2008, Gray, 
2006, Nelson, 2008). 
Procedural Implicit Memory 
Procedural memory, a branch of implicit memory, accounts for learned motor skills, 
habits, and tacit rules. The acquisition of procedural memories occurs below the level of 
conscious thought through repetitive actions. Some of the major brain areas involved in 
implicit memory include the basal ganglia, motor cortex, and cerebellum (Carlson, 2008). 
One example of implicit memory is knowing how to ride a bike. As everyone knows, the first 
attempt at riding usually results in failure. However, the skill can be mastered through 
successive attempts. While we are aware of our improvement, we are not conscious that 
sensorimotor learning is taking place that allows us to stay on the bike.  
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One subcategory of procedural memory, rule-based procedural memory, can be 
demonstrated through artificial grammar tests. Artificial grammar tests involve a set of rules 
that dictate which letters may be placed next to each other. For example, one rule may be that 
X’s must be followed by either X’s or Y’s. During the test, subjects are not explicitly told the 
rules, but rather given examples of grammatical and non-grammatical strings of letters. Later, 
subjects are given new strings of letters and asked if they think the strings fulfill the 
requirements to be considered grammatical. While participants are typically unable to 
explicitly state the requirements for a string to be considered grammatical, they are able to 
correctly define them as such because the rules have been implicitly learned (Gray, 2006). 
Classical Conditioning 
Classical conditioning, another type of implicit memory, is primarily dependent on 
the cerebellar circuit (Lindquist, 2007). During classical conditioning, an association is 
learned between two stimuli; an unconditional stimulus (UC), something that elicits a natural 
response; and a conditional stimulus (CS), something that does not elicit a natural response. 
The UC and CS are paired together during a series of trials until the CS elicits the same 
response as the UC, at which point the CS is said to be a conditioned response (CR). The 
most well recognized example of classical conditioning is Pavlov’s work with dogs, an 
experiment in which he was able to condition them to salivate at the sound of a bell. In this 
example, the presentation of food serves as the CS, with salvation as the natural response. 
The bell is the UC, as it does not normally elicit a salivatory response. Upon several weeks of 
pairing the ringing of the bell with the presentation of dinner, an association was formed 
between the two stimuli. Eventually the dogs began salivating at the sound of a bell even in 
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the absence of food (CR). This indicates that an implicit association between dinner and the 
bell had been learned.  
Priming 
The final kind of implicit memory, priming, refers to the process by which previous 
exposure to a stimulus elicits an exaggerated response upon later exposure to the same 
stimulus (Gazzaniga, 2009). The most common assessment of priming memory is the word-
stem completion test. During the first stage of the test, a participant is asked to study a list of 
words. A short time later, anywhere from a few minutes to a few hours, the participant is 
presented with word-stems that have multiple possible completions and is asked to complete 
the stem with the first word that comes to mind. For example, the participant is presented 
with the stem “Mot” with the target word, motel, having appeared on a previously 
encountered word list. Studies show that the participant is more likely to complete the stem 
with a word on the previously provided list as opposed to previously unstudied words if 
priming has occurred (Schacter, 1998).  
The most compelling evidence that priming occurs below the conscious level comes 
from the study of amnesic patients who have sustained brain damage to the hippocampus and 
or temporal lobes. While these patients are unable to recall recent experiences, a task that 
would involve normal brain function at the conscious level, they exhibit normal performance 
in priming tests (Schacter, 2001 & McDonald, 2010).   
Summary of Different Forms of Memory 
As described in the sections above, memory can be divided into several subcategories 
and involves a multitude of brain regions. Working memory has a relatively small capacity, 
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and is responsible for the short-term storage and manipulation of information that arrives 
from the sensory systems as well as LTM. If information contained within WM is rehearsed 
enough, it can be transferred to LTM, which has a nearly endless capacity. It should now be 
apparent that memory formation and storage is a very complex system that involves several 
cortical regions. The study of memory acquisition and consolidation of information within 
WM will be the main focus of this paper. How the cholinergic system facilitates hippocampal 
dependent memory formation will be addressed in the upcoming sections.  
 
Types of Memory Tests 
Several methods have been developed to test the effects of various drugs on memory 
through behavioral observations. Some of the most common tests for evaluating short-term 
memory and working memory are the Brown Peterson Test, the Novel Object Recognition 
Test, the Morris Water Maze, and several others. In order to gain a more complete 
understanding of how the brain works, these behavioral tests can be paired with tests 
showing biological mechanisms and cellular activity, such as RT-PCR and 
immunohistochemistry. The purpose of this section is to briefly introduce some behavioral 
tests that have become a mainstay of neuroscience research. They will frequently reappear in 
later sections as they provide excellent models for understanding how memory formation 
occurs.  
The Brown Peterson Test 
The Brown-Peterson Test is a commonly employed technique used to evaluate short-
term memory function. In the first part of the test, subjects are given a string of short words 
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(three to four letters) to remember. After receiving the string of words, subjects are asked to 
perform a 20-30 second “distraction task”. The distraction task is usually something simple, 
such as counting backwards by 3s. Once the distraction task has ended, the subjects are asked 
to recall the string of words. Numerous studies have proved that there is a negative 
correlation between the length of the distraction tasks and the number of words the subject is 
able to recall (Morrow, 2002). The Brown-Peterson task can be modified to test the effect of 
various drugs on short-term memory. For example, by administering nicotine before the word 
is presented, it is possible to increase the number of words a subject is able to recall after the 
distraction task. These results were also seen in a study using positron emission tomography 
(PET) in conjunction with the Brown Peterson test, which indicate that there is a positive 
correlation between Brown-Peterson test performance and hippocampal activity (Eustache, 
1995).  
The Nonrecurring-Items Delayed Nonmatching-to-Sample Test (DNMS) 
The nonrecurring-items delayed nonmatching-to-sample (DNMS) task was created to 
test non-spatial working memory such as object recognition. The DNMS test was first used 
to test non-spatial working memory in monkeys and was eventually modified to test non-
spatial working memory in rats as well  (Mumby, 1990). Additionally, DNMS has been used 
to elucidate the role of various brain areas in object recognition. For example, one study 
shows that by lesioning the hippocampus before the trials began, rats exhibited severe 
deficits in object recognition (Mumby, 1992).  
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The T-Maze 
The T-maze is an apparatus commonly used to study spatial memory and other 
hippocampal-­‐dependent processes. The maze, as the name suggests, is shaped like the letter 
T. During the first trial a subject, usually a rat, is placed at the base of the T and allowed to 
explore the maze. The trial is over once they reach the end of one of the arms at the top of the 
T. Countless studies show that if the subject is placed at the base of the maze for a second, 
consecutive trial, the natural tendency is to alternate which arm is explored. This tendency is 
known as spontaneous alternation. Researchers are able to reinforce spontaneous alternation 
by giving a reward if the animal alternates which side they choose between subsequent trials. 
Like the Brown-Peterson test, the T-Maze protocol can be modified to explore the effects of 
various drugs on behavior. Studies show that both surgical and neurotoxic induced lesioning 
of the hippocampus can disrupt spontaneous alternation behaviors, implicating a role for the 
hippocampus in spatial memory formation (Farr, 2000 & Volpe, 1988). 
 
The Morris Water Maze 
The Morris Water Maze (MWM) is another behavioral test that is frequently used to 
assess spatial memory formation and other forms of hippocampus-dependent learning. Its 
designer, Richard Morris, originally used the maze to demonstrate that hippocampal legions 
caused severe spatial learning impairments in rats (Figure 6). The maze itself consists of a 
round pool in a room with visual cues placed around the edges and an escape platform 
submerged slightly under the surface of the water. The rat is placed in the pool and the time it 
takes (latency) to reach the escape platform is recorded. As the rat is subject to more trials the 
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escape latency decreases, indicating that spatial memory formation has occurred. As in the 
previously mentioned behavioral tests, the MWM protocol can be modified in order to 
determine the effects of various drugs on learning and memory processes. The Morris water 
maze has a distinct advantage over the T-maze for studying spatial memory formation in that 
there are no fixed formals that the rat can memorize, such as learning that a reward is granted 
when the chosen side is alternated (Morris, 1984).  
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The Novel Object Recognition Test 
The Novel Object Recognition (NOR) test is one of the most frequently used methods 
of studying hippocampus-dependent memory formation. The NOR tests is based on a rat’s 
unconditional predisposition to explore novel objects significantly more than objects which 
they have previously encountered. A typical NOR protocol involves two trials: the 
familiarization trial and a test trial (Figure 7). The day before the familiarization trial, the rat 
is placed in the testing apparatus for a few minutes in order to acclimate with its 
surroundings.  
During the familiarization trial the rat is placed in a box with two different objects 
that are affixed to the box for a short period of time. The amount of time rat spends exploring 
both objects is recorded. Once familiarization is complete, the rat is removed from the box 
and placed back in its cage. At this point, one of the original objects is replaced with a new 
(novel) object, while the other (familiar) object remains untouched. After a period of time has 
passed, the rat is returned to box for the test trial and the amount of time rat spends exploring 
both objects is recorded. Countless studies show that the rat will spend significantly more 
time exploring the novel object than the familiar object during the test trial due to their 
natural predisposition to investigate novel objects (Broadbent, 2009). This type of NOR test 
is considered a one-trial object recognition tasks, and has been implemented in trying to 
understand many different aspects of memory formation. 
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The basic NOR procedure can be modified in a variety of ways to test different 
aspects of memory formation. For example, one study was able to prove that the 
hippocampus is involved in memory formation. This was done by adding a step to the 
previously mentioned NOR procedure between the familiarization and the test trial test trial. 
Between the two trials, half of the rats in the study underwent a procedure in which their 
hippocampal tissue was lesioned. The other half of the rats in the study remained untouched, 
serving as a control group. During the subsequent test trial, the rats that had received the 
hippocampal lesions exhibited moderate to severe memory impairment indicating that 
hippocampus played a role in object recognition (Gaskin, 2010).  
 
Considerations for Experimental Design 
There are a variety of testing condition issues that need to be taken into account when 
performing a NOR study. One of the most important issues is understanding to what degree 
the animals relate to the intrinsic properties of the objects used in the study. For example, it 
was found that rats show preference for objects that they are able to “interact” with. In other 
words, rats prefer objects that they are able to climb on or crawl into verses those that they 
cannot, regardless of how many times they have seen the objects in the past (Chemero, 
2005). One way to make sure that object preference does not confound the results is to make 
sure that all objects are roughly the same height. Another way to control for differences in 
object sizes is to elevate the objects above the rat’s normal visual zone. When an object is on 
ground level, the top of the object is the primary focus as the rat has the most interaction with 
the top through climbing activities. By placing objects on clear glass jars approximately 6 cm 
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high, the rat gains a more complete perspective of the object as a whole that results in a more 
complete memory formation (Mumby, 1990). 
Rats are unable to see as broad of a color spectrum as humans. Recent studies have 
shown that rats are more attuned to differences in brightness rather than colors, meaning that 
two different colors of similar brightness may look very different to humans but identical to 
rats. For this reason it is important to choose objects that not only vary in color but also 
brightness (Jacobs, 2001).  
Odor also plays an important role in memory and recognition processes. Using the 
same objects in multiple studies and with different animals may create an unintentional bias. 
If during a trial, a subject explores and touches one object preferentially over another, they 
may impart an odor on that object, which could affect how the next subject interacts with it. 
Therefore, the objects should be washed between animals (Ennaceur, 2010). 
Immunohistochemistry  
While the previously described behavioral tests examine learning and memory 
through behavioral observations, they do not provide an understanding of the changes in 
neural activity that are responsible for the behavioral changes. One of the most common 
ways to visualize changes in neuronal activation is to use immediate-early genes (IGE)  
immunohistochemistry, as the induction of IGEs is commonly associated with increases in 
neuronal activity. One IGE, c-Fos, encodes for a transcriptional factor. Because basal levels 
of c-Fos are low, an increase in c-Fos is representative of an increase in gene activity 
(Kovacs, 1998 & Worley, 1991). Because the c-Fos gene codes for a transcription factor,  
only nucleus of the cell is labeled during immunohistochemistry staining.  
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Immunohistochemistry can also be used to visualize the presence of various 
neurotransmitters within the cell. This technique was first used to visualize the anatomical 
location of cholinergic neurons in the rat brain. As mentioned on page 9, acetylcholine is 
assembled by the biosynthetic enzyme, choline acetyltransferase (ChAT). As demonstrated 
by Armstrong and colleagues, it is possible to determine the neuroanatomical location of 
cholinergic neurons within the rat brain using anti ChAT primary antibodies. Using this 
technique, a large concentration of reactive cells was found within the medial septum as 
expected (Armstrong, 1983). Due to the fact that acetylcholine is assembled within the 
cytoplasm of the cell, immunohistochemistry results in staining of the whole cell. 
By using c-Fos and ChAT antibodies in a dual staining immunohistochemistry 
procedure, it is possible to visualize cholinergic neurons in the medial septum that have 
recently undergone increased levels of activation (Modirrousta, 2004).  
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The link between smoking and working memory 
Although nicotine has been shown to have cognitive effects in humans, the 
mechanisms by which it causes these effects are still unclear. In a study to determine the 
effects of nicotine on life-long non-smokers, it was determined that subjects given nicotine 
instead of a placebo performed better in a variety of working memory orientated tasks: 
producing faster, more accurate responses (Kumari, 2003). Several studies have also reported 
that nicotine withdrawal has a negative effect on cognitive tasks involving working memory. 
Understanding how chronic nicotine administration via smoking cigarettes affects 
neurophysiology is a rapidly growing field of research. 
Human Studies 
Numerous human studies have shown that the effects of chronic smoking followed by 
abrupt withdrawal can have a negative effect on performances in working memory tasks, 
especially those that involve recognition memory. It is possible that these deleterious effects 
contribute to the social and physiological factors associated with nicotine dependence, and 
are therefore associated with the difficult task of quitting smoking (Mendrek, 2006). 
Furthermore, studies show nicotine deprivation causes a significant decline in mood, which 
may contribute to the psychological aspect of nicotine dependence (Heffernan, 2005). 
Due to the all of the negative health effects associated with smoking cigarettes, the 
primary method of nicotine delivery into the body, some studies set out to determine the 
effects of nicotine in humans when delivered via battery operated electronic cigarettes (e-
cigarettes). The use of e-cigarettes provides a potentially safer nicotine delivery system 
because no tobacco is burned in the process, eliminating the normal co-inhalation of tar and 
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carbon monoxide. Replacing normal cigarettes with e-cigarettes has been shown to help curb 
withdrawal symptoms during the quitting process. One study found that some brands of e-
cigarettes cause both a reduction in the desire to smoke as well as a reduction in the severity 
of withdrawal symptoms without actually raising blood nicotine levels (Vansickel, 2010). 
Further studies confirmed this notion by using cigarettes that contain denicotinized tobacco. 
These findings show that simply performing the physical processes associated with smoking 
help to curb withdrawal symptoms, and that nicotine addiction has both a biological and 
psychological component (Rose, 2010). 
Using the Brown-Peterson task it was determined that nicotine inhalation via e-
cigarettes was able to improve attention to and speed of visual-spatial processing in humans. 
Likewise, a Brown-Peterson Memory test, commonly used to evaluate working memory, 
showed that e-cigarettes also improve recognition memory performance (Dawkins, 2012). 
 
Nicotine and Cognition: the Hippocampus and Perirhinal Cortex. 
It has been suggested that many of nicotine’s effects on cognitive behavior involve 
areas of the brain that have projections into the hippocampus, a structure largely involved in 
spatial recognition memory (Gray, 1994). There are several subtypes of nAChRs located 
within the hippocampus. Two subtypes, α7 and α4β2, are thought to contribute to synaptic 
plasticity due to their location on both pre- and postsynaptic membranes. This dual location 
is thought to increase their ability to modify synaptic transmission and neurotransmitter 
release, consequently increasing synaptic plasticity (Kenney, 2008). The α7 and α4β2 
nAChRs have also been found in other brain areas involved in recognition memory, such as 
the perirhinal cortex (Melichercik, 2012). The location and subtypes of nAChRs within the 
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 The following information about the organization of the hippocampus is summary 
adapted from The Hippocampus Book (Anderson, 2007). The hippocampus has a unique, 
unidirectional circuitry, which allows it to effectively process information from a variety of 
cortical regions (Figure 9). Its unique circuitry enables it to integrate incoming, afferent 
sensory information with previously made associations stored in long term memory. There 
are three main divisions in the hippocampus: The dentate gyrus, CA1, and CA3/CA2. The 
main source of hippocampal input comes from the entorhinal cortex and arrives in the 
granular cells of the dentate gyrus (DG). Information is then relayed via mossy fiber 
synapses to the pyramidal cells of CA3 where it is processed through a variety of recurrent 
connections. After processing, information is sent both to the pyramidal cells of the CA1 and 
to the contralateral hippocampus via Schaffer collateral synapses. After processing, 
information exits the hippocampus through the subiculum and terminates in various parts of 
the cortex (Figure 10). 
















(A) The Hippocampus with CA1, CA3, and the DG highlighted, (B) the Perirhinal cortex 
(adapted from Paxinos, 2007) 
  









The entorhinal cortex (EC) provides the main source input to the hippocampus via the 
perforant pathway (PP). The cells of the PP terminate on the molecular layer of the dentate 
gyrus (DG) as well as the stratum lacunosum-molecular (SL-M) layer of the pyramidal cells 
of CA3. Mossy fiber projections (MF), which also originate in the DG, terminate just above 
the pyramidal layer of CA3. There are a large amount of recurrent collaterals (RC) pathways 
within CA3. Schaffer collateral connections (SC) connect CA3 to CA1. From CA1 
information travels out of the hippocampus to the Perirhinal cortex (PRh) and back to the EC. 
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The Dentate Gyrus 
The dentate gyrus (DG) is a “V” shaped formation of cells that is the first stop for 
information coming into the hippocampus. There are  three distinct cell layers present in the 
DG: the molecular layer, the principle layer, and the polymorphic layer.   
The molecular layer of the DG is superficially located closest to the hippocampal 
fissure. For the most part, it is composed of granular and basket cell dendrites originating 
from bodies located within the principle layer.  While the molecular layer contains a few 
multipolar cells, it is relatively free of cell bodies as compared to the other two layers. The 
few cell bodies that it does contain are GABAergic and provide inhibition to the granular 
cells of the principle layer.  
 The principle layer of the DG, often referred to as the granular cell layer, is located 
just under the molecular layer. The principle layer is densely packed, ranging anywhere from 
4-8 granule cells thick and often times there is no glial sheath between adjacent cells. Dentate 
granule cells found in the principle layer are primarily glutamatergic. Their dendrites form 
tree or cone shaped projections that point towards the superficial plane of the molecular layer 
and are responsible for sending projections to other hippocampal region, primarily CA3. It 
has been estimated that there are approximately 1.2 million granular cells in the human 
hippocampus.  
Pyramidal basket cells, a type of GABAergic interneuron, are the main inhibitory 
cells within the principle layer.  As their name suggests, they have a pyramidal cell body. 
The basket nomenclature denotes the shape of their dendrites, which surround and form 
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synapses with the synapses of the granule cells. Although fewer in number and less well 
defined, other types of GABAergic interneuron can be found in the principle layer.  
The outermost layer of cells that encloses the DG is known as the polymorphic layer. 
The polymorphic is composed of a very diverse cell population whose function remains 
largely unknown. Mossy fiber cells are the most prevalent cell type found in the polymorphic 
layer. These cells have large bodies that are triangular or multipolar. They usually have at 
least three long dendrites that travel great distances within, but virtually never leave, the 
polymorphic layer.  
Afferent Projections Arriving at the DG 
The main source of input into the hippocampus comes from the entorhinal cortex via 
the perforant pathway, which terminates at the molecular layer of the DG as well as on the 
pyramidal cells of CA3. The medial septum nucleus (MS) and the diagonal band of Broca are 
also responsible for sending information to the hippocampus by way of the entorhinal cortex. 
While the majority of these afferent projections are cholinergic, GABAergic projections are 
present as well. Interestingly, there is a large amount of specificity where GABAergic axons 
usually terminate only at GABAergic nonpyramidal cells, such as basket cells; while 
cholinergic projections usually terminate only at the excitatory granule cells of the DG.  
Efferent Projections Out of the DG 
CA3 is the only region within the hippocampus to be innervated by the DG. These 
connections consist of mossy fiber projections from granule cells in the principle layer of the 
DG and terminate just above the pyramidal layer of the CA3 in the stratum lucidum. Mossy 
fibers projections have many unique features: they have unusually large, highly complex and 
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irregular terminals that form connections with proximal CA3 pyramidal dendrites; they have 
a large number of active zones; and they can make as many as 37 connections with a single 
CA3 pyramidal cell. Mossy fiber active zones usually synapse with a single pyramidal cell. 
Individual mossy fibers can have up to 15 active zones, making it able to connect with 15 
pyramidal cells. Due to the disproportionate number of granule cells to pyramidal cells, each 
pyramidal cell is able to receive information from 72 different granule cells. 
CA1, CA2 & CA3 
The laminar organization is well conserved throughout the hippocampus. The 
pyramidal cell layer (PCL) is the principle cell layer. It consists of tightly packed cells in 
CA1 and slightly more loosely packed cells in CA2/3. The stratum oreins (SO) is located just 
under the PCL and consists mainly of pyramidal cell dendrites and various interneurons. The 
Stratum radiatum (SR) is often referred to as the suprapyramidal region, and is located on the 
other side of the PCL. This region is home to both CA3 - CA3 recurrent collaterals  and CA3 
- CA1 Schaffer collateral connections. The most superficial layer of the hippocampus, called 
the stratum lacunosum-molecular (SL-M), is located just above the SR (Figure 11).  
Pyramidal cells are the most prevalent neurons found in the hippocampus. Their cell 
body is located within the PCL, with a basal dendritic tree that extends into the SO, and an 
apical dendritic tree with projections terminating in both SR and SL-M. There are also 
several groups of GABAergic interneurons found throughout all layers of the hippocampus. 
The most prevalent of these cells, the basket pyramidal cell, has a cell body located either in 
the PLC or the SR and dendritic extensions into the SO, SR, and SL-M (Figure 12). A typical 
basket cell is able to innervate as many as 1000 pyramidal cells. Another class of 
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interneuron, the interneuron-selective (IS) neuron, has axons that connect exclusively to 
other interneurons. Furthermore, there are several other interneurons with similar 
morphology to the basket cell, such as the bistratified cell and chandelier cell. The main 
source of output from the hippocampus originates at CA1 which sends the majority of 
outgoing information the entorhinal cortex and perirhinal cortex.  
The previous sections provide a simplified anatomical description of the laminar 
organization of the hippocampus. While the information presented above will serve as a basis 
for understanding one way in which the cholinergic system influences hippocampal memory 
formation, research into this complex circuitry is still underway.  
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Hippocampus dual stained with c-Fos and ChAT. (o) stratum oriens, (p) stratum pyramidale, 
(sr) stratum radiatum, (sl-m) stratum lacunosum-molecular, (m) dentate molecular layer, (g) 
granule cell layer.   
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Learning and Memory: a General Role for the Hippocampus  
The CA1 and CA3 regions of the hippocampus have repeatedly been associated with 
memory formation. The rapid influx of information to CA3 causes a change in synaptic 
plasticity that leads to the formation of associations between previously unrelated stimuli 
(Do, 2000). Since CA3 receives information from a variety of sources and is involved in 
physically making new associations, it is thought to play a role in the formation of working 
memory, spatial memory, and shock avoidance behaviors. CA1 also receives information 
from a variety of different cortical regions implicated in spatial and temporal pathways. For 
example, mice that have undergone surgical procedures disrupting CA1 were unable to form 
cognitive spatial maps and retrieve spatial information (Daumas, 2005). In addition to their 
roles in spatial memory function, CA1 and CA3 have also been implicated in the formation 
and consolidation of long-term memories (Kenney, 2008). It is hard to consistently delineate 
the boarders of CA2 between studies, therefore less research into its functioning has been 
performed. However, due to its location between CA1 and CA3, CA2 is also thought to be 
involved in these memory processes.  
 
6. The Perirhinal Cortex 
6.1 General Structure 
The perirhinal cortex (PRh) is located on the surface of the temporal lobe near the 
visual cortical area. The exact boundaries of the PRh are not universally agreed upon. In fact, 
a large degree of variation can be found when trying to delineate its boundaries from various 
scientific papers. Like the hippocampus, the PRh contains nAChRs, however, it is not 
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thought to be significantly involved in spatial memory recognition tasks, but rather it object 
recognition tasks (Parker and Gaffan, 1998). The perirhinal cortex receives information from 
a variety of cortical regions involved in making associations as well as the visual, auditory, 
olfactory, and somatosensory cortexes. Some of the most well studied afferent projections 
terminate at the caudate nucleus, putamen and the nucleus accumbens.  
The PRh also has reciprocal connections, meaning it both sends and receives 
information, with several brain areas such as the entorhinal cortex; the main source of input 
to the DG and therefore hippocampus (Canning, 1997). Due to the close proximity of the 
PRh and entorhinal cortex, they are frequently grouped together and referred to as the rhinal 
cortex (Brown, 1997). Reciprocal connections can also be found between the PRh and 
amygdala, as well as the PRh and thalamus. Several of these reciprocal  pathways are capable 
of undergoing LTP, providing a possible mechanism for memory formation (Liu, 1996).  




























Arrow thickness indicates relative amount of information flow between brain regions 
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Differences Between the Perirhinal and Hippocampal Dependent Memory 
While the perirhinal cortex and hippocampus are both involved in recognition memory 
they serve unique, distinct, functions. It is thought that the PRh is primarily responsible for 
recognizing that an object has previously been encountered, while the hippocampus is 
responsible for knowing the circumstances surrounding the last time the object was 
encountered (Brown, 1997).  
 
Lesioning Studies 
The distinctive roles of the hippocampus and PRh have been demonstrated using 
lesioning studies. For example, spatial memory in rats, as assessed by the Morris Water 
Maze, was impaired upon receiving hippocampal lesions (Broadbent, 2006). Severe memory 
deficits caused by hippocampal lesioning were also demonstrated using the Novel Object 
Recognition Test (Gaskin, 2010). Interestingly, no memory deficits were observed in rats that 
had received hippocampal lesions as assessed by the nonrecurring-items delayed 
nonmatching-to-sample (DNMS) test (Mumby, 1992). Since the DNMS is used to test non-
spatial object recognition, while the WMW and NOR are used to test spatial object 
recognition, these results suggest that the hippocampus is more involved in object location 
rather than object recognition memory processes. 
An inverse pattern of memory disruption is present upon examining the effects of 
perirhinal lesions on object recognition and object location memory. In a equivalent DNMS 
experiment to that of Mumby and colleagues described above, rats that received neurotoxic 
lesions to the perirhinal cortex showed severe deficits in object recognition memory 
(Ennaceur, 1996). Severe impairments in object recognition caused by perirhinal lesioning 
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has also been observed in monkeys using the DNMS test (Meunier, 1993, Parker and Gaffan, 
1998). Unlike with hippocampal lesions, lesions to the perirhinal cortex to not appear to 
disrupt spatial memory processes. Wiig and colleagues demonstrated that rats who received 
perirhinal cortex lesions did not display deficits in spatial memory as measured by the MWM 
(Wiig, 1940). These experiments suggest that unlike the hippocampus, the perirhinal cortex 
is more involved in object recognition rather than object location memory processes. 
Intriguingly, studies show that surgically disconnecting the hippocampus from the perirhinal 
cortex causes severe memory impairments for both object recognition and object location 
tasks (Warburton, 2003). Therefore, communication between the hippocampus and PRh must 
be necessary for both object recognition and object location tasks. 
 
Immunohistochemistry Studies 
A distinct functional separation between the hippocampus and PRh can be visualized 
using immediate early gene (IEG) activation patterns. Immunohistochemistry c-fos studies 
show that PRh neurons undergo a higher level of activation following exposure to novel 
visual stimuli than familiar visual stimuli, a pattern not seen in the hippocampus (Zhu, 1995). 
An inverse pattern of activation can be seen in the hippocampus when using c-fos 
immunohistochemistry to determine neuronal levels of activation in response to novel versus 
familiar environments. Activation due to changes in environment are more closely related to 
location memory while activation due to changes in visual stimuli are related to object 
recognition memory (Wan, 1999). Taken together, the lesioning and immunohistochemistry 
studies show that while the PRh and hippocampus play distinct roles recognition memory, 
communication between the two regions is crucial for memory formation. 
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Learning and Memory: A General Role for the Perirhinal Cortex 
The commonly accepted mechanistic theory for how the perirhinal cortex is able to make 
distinctions between novel and familiar objects is based on synaptic plasticity. Similar to the 
CA3’s aforementioned ability of to make spatial connections, the simultaneous influx of 
information from several cortical regions pertaining to an objects physical attribute, such as 
color and size, causes in changes in neuronal wiring in the PRh. These new connections 
create a consolidated representation of an object’s physical properties which is the basis of 
object recognition memory (Murray and Richmond, 2001).  
Slice studies performed on the rat perirhinal cortex show that as the PRh is repeatedly 
exposed to a stimulus, the neuronal response to that stimulus declines. This reduced response 
does not fade or diminish over time. It provides a mechanistic explanation for how the PRh is 
able to facilitate object discrimination and is commonly referred to as long-term depression 
(LTD) (Warburton, 2003). Just as in the hippocampus, pre and post synaptic nAChR activity 
may help modulate LTD facilitated synaptic plasticity in the PRh.  
By using scopolamine to block mAChRs during acquisition, retrieval, and consolidation, 
Winters and colleagues tested how ACh levels in the PRh are involved different stages of the 
novel object recognition test. In order to determine the role of ACh in memory acquisition, a 
cannula was used to deliver an intra-PRh injection of scopolamine prior to the familiarization 
trial. Rats treated with scopolamine performed significantly worse during the test trial than 
those treated with saline, indicating that ACh in the PRh is necessary for memory acquisition. 
Scopolamine administration directly after the familiarization trial did not produce any 
negative effects during the test trial, indicating that ACh may not play a role in PRh 
consolidation. Interestingly, rats given the intra-PRh scopolamine infusions three hours prior 
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to the test trial (after the consolidation period) performed significantly better during the test 
trial than those given saline (Winters, 2006). In a subsequent set of experiments it was 
determined that these enhancing effects were due to interference prevention caused by low 
ACh levels. Essentially, when a novel object is presented between the familiarization and test 
trials a new memory gets formed. This new memory can interfere with the memory formed 
during the familiarization trial, in a process known as retroactive interference. Studies show 
that retroactive interference is able to be avoided by administering an intra-PRh infusion of 
scopolamine prior to the presentation of the extraneous object. Scopolamine is able to 
enhance memory formation in this test by blocking the acquisition of the interfering object, 
allowing for the previously encoded memory to remain unadulterated (Winters, 2007). These 
experiments provide strong evidence that recognition memory processes in the PRh are 
mediated by ACh. While there has been some research into the workings of the perirhinal 
cortex, further research is needed to solidify its exact role in memory formation.  
 
Modification to the Cholinergic System Disrupts Memory Processes 
There is overwhelming amount of evidence implicating the cholinergic system in a 
variety of learning and memory processes. It is largely accepted that the cholinergic system 
able to mediate these processes via the release of the neurotransmitter, acetylcholine (ACh). 
The first line of evidence indicating that ACh helps facilitate memory formation 
comes from research showing that cholinergic projections from basal forebrain to the 
hippocampus and frontal cortex release ACh upon exposure to a novel stimulus.  In primates, 
activation of basal forebrain neurons upon exposure to a novel stimulus occurs at a higher 
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level when the stimulus is associated with something that is advantageous; such as a reward 
or punishment (Wilson, 1990). In other words, the degree to which a  novel stimulus directly 
affects an animals life is correlated with how well the animal remembers that stimulus.  
  
Microdialysis:  Real-Time Measurements of Neurotransmitter Release 
ACh is Released Upon Exposure to Novel Stimuli, a Microdialysis Study  
By implanting a microdialysis probe in the brain of a living animal, researchers are 
able to measure fluctuations in the release of neurotransmitters in real time. For example, 
exposure to a novel environment has been shown to cause elevated levels of ACh in the 
hippocampus using microdialysis technique. Microdialysis has also been used to measure the 
amount of ACh released during different stages of a behavioral test by placing a probe in the 
basal forebrain. One study set out to determine the extent to which ACh was released in 
response to both conditioned and unconditioned stimuli in rats using three experimental 
groups (habituation, novel stimuli, and conditioned fear).  During the first phase of the 
experiment, training, rats were placed in the same apparatus for twelve, 20 minute sessions. 
During training, the habituation group received constant exposure to both light and sound 
stimuli, while the novel stimuli group were placed in the apparatus without receiving any 
stimuli. The conditioned fear group was exposed to the same stimuli as the habituation group, 
with the caveat that every time they were exposed to the light or sound stimuli they received 
a footshock.  
Microdialysis probes were placed in the frontal cortex and hippocampus after 
completion of the training trials. After recovering from surgery, the rats were returned to the 
apparatus and once again exposed to their respective conditions, except for rats in the novel 
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condition group which were exposed to the light and sound stimuli for the first time. Both the 
novel stimuli group (unconditioned stimuli) and conditioned fear group (conditioned stimuli) 
had significantly elevated levels of ACh in both the frontal cortex and hippocampus. The rats 
in the habituation group showed no changes in ACh levels between the two trials. These 
results indicate that ACh is released upon encountering novel stimuli, as in the unconditioned 
stimuli group, and behaviorally relevant, as in the conditioned fear group, but not upon 
experiencing familiar, non relevant stimuli as in the habilitation group (Acquas, 1996). 
Furthermore, an increase in exploratory behavior is seen upon exposure to a novel 
environment, suggesting a role for ACh in instigating investigatory behaviors (Thiel, 1998).  
ACh is Released in Learned Anticipation Tasks 
Another study using in vivo microdialysis determined that ACh is involved in learned 
anticipation tasks. In this study, rats were placed in a testing apparatus and given either water 
or liquid chocolate before being returned to their home cage. Once a day for 14 days the rats 
were given their respective treatment with the idea being that rats that received chocolate 
would learn to anticipate this treat, while the rats given water served as a control group. On 
the 15th day, the same procedure was followed while monitoring hippocampal and frontal 
cortex levels of ACh. The rats used to receiving the liquid chocolate had significantly higher 
levels of frontal cortex and hippocampal ACh as compared to those given water, indicating a 
role for ACh in learned anticipation (Inglis, 1994). 
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Morris Water Maze: Spatial Memory 
Studies using the Morris Water Maze (MWM) have provided substantial evidence for 
understanding how ACh is involved in modulating learning and memory processes. The 
MWM consists of a round pool of water with various visual cues located around the edges 
and a hidden escape platform submerged a few millimeters below the surface. In the 
beginning of a trial, a rat is placed in the pool and the time it takes (latency) to reach the 
escape platform is recorded. As an animal undergoes several subsequent trials, their escape 
latency decreases, indicating that spatial memory formation has taken place and that the 
rodent has successfully completed the acquisition stage of training. In some studies, the 
rodent is examined further to determine the extent to which acquisition has led to a stable 
memory of the platform location. It is possible to study the effects of various drugs on spatial 
memory processes by administering treatments during different stages of the MWM 
procedure and recording changes in escape latencies.  For example, selectively destroying 
cholinergic neurons has been shown to cause deficits in memory acquisition using the MWM 
(Myhrer, 2003).  
IgG-192-Saporin Injections in the Hippocampus Disrupt Memory Acquisition, but not 
Consolidation  
The immunotoxin, IgG-192-saporin, selectively binds to and kills cholinergic cells in 
the basal forebrain and hippocampus, while sparing cholinergic cells in the brainstem. This 
same pattern of cell death is common in Alzheimer’s disease, making IgG-192-saporin a 
useful tool for creating an animal model of the disease (Nillson, 1992).  By injecting IgG-
192-saporin at different stages of the MWM, Nillson and colleagues were able to show that 
cholinergic neurons play a role in spatial memory acquisition. In their study, a cohort of rats 
was divided into three groups (control, acquisition, and consolidation) before receiving 
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bilateral hippocampal cannulas. After recovering from surgery, the rats underwent several 
training sessions to familiarize them with the MWM. The rats in the acquisition group 
received 4ug/kg IgG-192-saporin before the training sessions, while the rats in the 
consolidation group were injected after the training sessions. The rats in the control group did 
not receive any drug infusions. After the training sessions, the rats underwent a series of six 
trials to calculate their escape efficiency. The rats in the acquisition group had significantly 
longer escape latencies than those in the consolidation or control group. Additionally, there 
was no significant difference in escape latencies between the consolidation or control group. 
Taken together, these results indicate that cholinergic neurons are involved in memory 
acquisition, but not consolidation processes (Walsh, 1995).  
Scopolamine Injections in the Hippocampus Disrupt Memory Acquisition, but not 
Consolidation 
Another common way of studying what a particular neurotransmitter does is by 
understanding how it affects different receptor systems. For example, studying what happens 
upon activation or inhibition of mAChRs and nAChRs has helped scientists piece together 
the role of the cholinergic system in memory formation. Researchers have numerous drugs at 
their disposal that are selective for specific mAChR and nAChR subtypes. Administering 
receptor agonists allow researchers to examine behavioral changes as a result of augmented 
receptor functioning, while receptor antagonists can be used to temporally interrupt receptor 
function.  
The role of muscarinic acetylcholine receptors (mAChRs) in memory processes has 
been extensively researched. In one set of experiments, hippocampal cannulas were used to 
deliver bilateral infusions of scopolamine, a potent mAChR antagonist, at different stages of 
testing in the MWM. As in the IgG-192-saporin study mentioned above, a cohort of rats was 
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divided into three different groups: control, acquisition, and consolidation. The rats in the 
acquisition group received scopolamine infusions before the training sessions, while the 
consolidation group received infusions after the training sessions. The rats in the control 
group did not receive any drugs, and as expected, they escaped progressively faster during 
the training and trial sessions indicating that spatial learning had taken place. There were 
significantly longer escape latencies for the rats in the acquisition group than in both the 
consolidation and control groups, implying mAChRs help to facilitate the acquisition of 
spatial memories. However, there was no significant difference in escape latency between the 
consolidation and control groups, indicating that mAChRs do not influence the consolidation 
of spatial memories (Riekkinen, 1997). 
Pirenzepine Disrupts Memory Acquisition  
Some research has attempted to examine the role of specific mAChR subtypes on 
memory acquisition using the M1 muscarinic receptor antagonist, pirenzepine, with similar 
testing protocols as those described above. Although not conclusive, it is thought that M1 
receptor inhibition leads to impaired memory acquisition. Due to pirenzepine’s low level of 
selectivity for the M1 receptor, these effects may have actually been mediated by M2 
receptor inhibition as well (Hunter, 1988). More research needs to be performed in order to 
elucidate the exact roles of the various mAChR subtypes. 
Mecamylamine and Hexamethonium Disrupt Memory Acquisition, but not Consolidation 
The role of nicotinic acetylcholine receptors (nAChRs) in memory formation has also 
been expansively researched using the MWM. In this version of the MWM test, the rats were 
divided into four groups, mecamylamine i.p. 3mg/kg, mecamylamine i.p. 10mg/kg, 
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hexamethonium i.c.v., and saline. Mecamylamine is a nicotinic antagonist active in the CNS, 
while hexamethonium is a peripherally acting nicotinic antagonist. The effects of the 
nicotinic antagonists were tested for both acquisition and consolidation processes. 
 The escape latencies revealed a significant drug effect at both mecamylamine doses 
when given before the acquisition trials. While still significant, the escape latencies of the 
rats given hexamethonium injections were comparable to those that received the lower dose 
of mecamylamine. These findings demonstrate that nicotinic antagonists are able to disrupt 
acquisition, implicating nAChR activity in the memory acquisition process. These effects 
were not observed when the drugs were administered between training and trial sessions, 
suggesting that memory consolidation processes are independent of nAChR function 
(Decker, 1992). 
Phenserine, an AChE inhibitor, Restores Scopolamine - Induced Memory Deficits 
Administration of acetylcholinesterase (AChE) inhibitors allow ACh to elicit a 
greater synaptic response by delaying the enzymatic degradation of ACh by 
acetylcholinesterase. AChE inhibitors have been shown to have a restorative effect on 
memory deficits induced by scopolamine. 
Administration of the AChE inhibitor, phenserine (PHEN), has been shown to have a 
restorative effect on memory deficits induced by scopolamine. In a recent study rats were 
acclimated to the MWM before receiving one of the following i.p. treatments: saline (CON), 
1.0mg/kg scopolamine (SCOP), 1.0mg/kg PHEN (PHEN1), 2.0mg/kg PHEN + 1.0mg/kg 
scopolamine (PHEN2),  or 4.0mg/kg PHEN + 1.0mg/kg scopolamine (PHEN4). After 
receiving their respective treatments, the rats underwent 4 more trials, during with their 
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escape latencies were measured. As expected, the rats in the SCOP group had significantly 
longer escape latencies than those in the CON group. The escape latencies of rats in the 
PHEN4 group were significantly shorter than those in the SCOP group, showing that by 
using an AChE inhibitor it is possible to reverse spatial learning deficits caused by attenuated 
cholinergic function (Janas, 2005). 
 
Novel Object Recognition 
The Novel object recognition (NOR) tests is based on rat’s natural tendency to spend 
a greater time exploring novel objects than objects which they have previously encountered, 
making it a valuable tool to examine object memory processes. A standard NOR test is 
comprised of two of trials, the familiarization trial and the test trial.  During the 
familiarization trial, the rat is placed in the testing apparatus (NORbox) with two different 
objects to investigate for a short period of time, before being returned to its cage. After a 
predetermined period of time, the rat is returned to the NORbox for the test trial. During the 
test trial, the NORbox contains one of the original objects along with one never before seen, 
novel object. The amount of time the rat spends exploring both objects is recorded with the 
expectation being that the rat will spend a greater amount of time exploring the novel object. 
By administering drug treatments at various stages of the experiment it is possible to 
determine the effects of these treatments on object memory processes (Broadbent, 2009). 
Nicotine Enhances Memory Both Object Recognition and Location Memory Formation 
In a series of experiments, Melichercik and colleagues demonstrated that pre-
familiarization, systemic, intra-perirhinal and intra-hippocampal nicotine administration is 
able to enhance both object recognition and location memory formation. A slightly modified 
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version of the novel recognition test was used to assess object recognition memory; A Y-
shaped apparatus was used instead of the standard NOR box. The Y-shaped apparatus 
contained two exploratory arms and one arm with a starting area separated by a guillotine 
door. The experiment started with the rat located in the starting area with the guillotine door 
lowered. To start the trial the door was raised allowing the animal free exploration of both 
arms. Once the animal exited the starting area the door was closed. During familiarization, 
identical objects (A and A1) were located in each arm, and the time the animal spent 
exploring each object was recorded. The test trial was conducted 72 hours after 
familiarization. During the test trial one arm contained a familiar object (A or A1), while the 
other contained a novel object (B), and the time the animal spent exploring each object was 
recorded. From this experiment it was determined that systemic, intra-perirhinal and intra-
hippocampal nicotine administration enhanced object recognition memory. 
A standard NOR apparatus test was used to examine object location memory by 
slightly modifying the protocol; during familiarization two identical objects were located in 
adjacent corners of the apparatus, and during the test trial the location of one object was 
moved (Figure 14). In order to form spatial associations for where the objects were located, 
several visual cues were present in the testing room. By changing the position of one object 
during the test trial, the translocated object gains novelty and therefore should be more 
thoroughly investigated during the test trial (Melichercik, 2012). These experiments 
demonstrate nicotine’s ability to enhance multiple forms of memory formation in various 
brain regions. 











Figure 14: Object recognition vs. object location NOR tests 
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Metrifonate and Donepezil (AChE inhibitors) Enhance Memory Acquisition for Object 
Recognition  
The NOR test has also been used to determine the effects of two AChE inhibitors, 
metrifonate and donepezil, on memory acquisition and consolidation. Prickaerts and 
colleagues administered oral does of the AChE inhibitors prior to familiarization in order to 
determine if AChE inhibitors can enhance memory acquisition. They discovered that the rats 
treated with either metrifonate and donepezil spent significantly more time examining the 
novel object during the test trial, as compared to those treated with saline in the control 
group. These results indicate that increased ACh levels are able to enhance memory 
acquisition.  
When metrifonate or donepezil were administered post familiarization, there was no 
change in exploration times during the test trial, suggesting that ACh may not be involved in 
consolidation (Prickaerts, 2005). Due to the improvement in memory acquisition facilitated 
by metrifonate and donepezil further signifies a role for acetylcholine in object recognition 
memory acquisition.  
IgG-192-Saporin Injections in the MS do not Disrupt Memory Acquisition for Object 
Recognition  
As previously mentioned, IgG-192-saporin induced lesioning of hippocampal 
cholinergic neurons has been shown to cause spatial memory acquisition impairments in the 
MWM. Furthermore, IgG-192-saporin induced lesions have been shown cause memory 
impairments using spontaneous alternation tasks such the T-Maze (Chang, 2004).  
Since the medial septum (MS) is the seat for cholinergic projections into the 
hippocampus, it was hypothesized that IgG-192-saporin induced lesioning of the MS may 
also produce memory deficits. In order to test this hypothesis, injections of IgG-192-saporin 
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into the MS were given between the familiarization and test trials of a standard NOR test. 
Amusingly, rats with MS lesions spent more time examining the novel object during the test 
trial, indicating that MS ACh projections to the hippocampus are not involved in the novel 
object acquisition process. Although these projections are not involved in novel object 
acquisition processes, they are thought to be involved in object location memory (Cai, 2012). 
IgG-192-Saporin Injections into the MS Disrupts Memory Acquisition in a Modified Object 
Location NOR Test 
In a subsequent study, rats received IgG-192-saporin induced lesions ACh neurons in 
the MS between the familiarization and test trials. This time they were tested using the 
previously mentioned object location version of the NOR test [sec 7.3.1] (Cai 2012). The rats 
given MS ACh lesions spent approximately the same about of time examining both objects 
during the test trial, indicating that ACh lesioning of the MS disrupts spatial memory 
formation. Taken together, the results of these two lesioning studies show that ACh 
projections from the MS to the hippocampus are involved in object location, but not object 
recognition memory formation (Cai, 2012).  
IgG-192-Saporin Injections into the PRH Disrupt Object Location Memory  
Bilateral injections of  IgG-192-saporin into the perirhinal cortex (PRh) have also 
been shown to cause object recognition memory acquisition deficits in a slightly modified 
NOR test. In this study rats received bilateral surgical implantation of cannulas into the PRH 
before familiarization. After recovering from surgery, one group of animals received IgG-
192-saporin infusions, while the other group received saline. The two groups then 
participated in a familiarization trial in which the NORbox contained two identical objects. 
During the test trial, one of the objects was replaced with a novel object. As expected, rats 
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that received only saline spent a greater proportion of time exploring the novel object during 
the test trial. However, those with PRh lesions spent the same proportion of time exploring 
the novel and familiar objects during the test trial, indicating that the cholinergic neurons in 
the PRh facilitate memory acquisition for object recognition (Winters, 2005). 
Both Systemic and PRh Specific Scopolamine Injections Disrupt Novel Object Recognition 
Memory Acquisition 
Just as in the MWM experiments, the role of mAChRs have been evaluated using the 
NOR test. By administering i.p. injections of the mAChR antagonist, scopolamine, before the 
familiarization trial it was determined that mAChRs help facilitate memory acquisition. In 
this experiment, rats were either treated with i.p. injections of saline or scopolamine, 
0.05mg/kg, prior to the familiarization trial. As expected, rats treated with saline spent 
significantly more time investigating the novel object during the test trial.  The rats treated 
with scopolamine showed no preference for the novel object during the test trial. The lack of 
discrimination between the novel and familiar object exhibited by the rats treated with 
scopolamine indicates that mAChRs help facilitate memory acquisition. These results are 
consistent with several NOR studies examining the effects of s.c. injections of scopolamine 
on memory formation in which scopolamine disrupts memory acquisition (Dodart, 1997 & 
Besheer, 2001).  Furthermore, bilateral infusions of scopolamine into the perirhinal cortex 
produced the same lack of object discrimination, specifying mAChR activity in the perirhinal 
cortex is involved in the acquisition process (Warburton, 2003).  
Systemic Scopolamine Injections Disrupt Object Recognition Memory Acquisition in a 
Modified NOR Test  
Other versions of the NOR test have been used to examine the effects of nAChR and 
mAChR antagonism on memory acquisition processes. One set of experiments conducted 
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Besheer and colleagues (2001) used a three chambered NOR apparatus instead of the 
standard one chamber NORbox. The modified NOR apparatus consisted of a small, central 
chamber flanked by two doors, each leading to a larger chamber. During the familiarization 
trial the doors remained closed and a rat was placed in one of the side chambers with a single 
object for 5 minutes. During the test trial, the previously encountered object remained in 
place while a novel object was placed in the other side chamber. To start the trial both doors 
were opened and a rat was placed in the central compartment. Just as in a typical NOR test, 
the assumption was that the rats would better remember the object encountered in the 
familiarization trial and therefore spend more time exploring the novel one during the test 
trial.  
Scopolamine was delivered s.c. (0.3, 1.0, and 3.0 mg/kg) twenty minutes prior to the 
familiarization trial in order to disrupt systemic mAChR functioning, while s.c injections 
saline served as a control. The rats given scopolamine spent approximately the same amount 
of time investigating both objects during the test trial for all doses, indicating that proper 
mAChR functioning is imperative for memory acquisition process; these results confirm the 
findings of the previously mentioned study [page 70].  
Systemic Mecamylamine Injections Disrupt Object Recognition Memory Acquisition in a 
Modified NOR Test 
Besheer and colleagues carried out the same experiment as in the previous section 
using the nAChR antagonist mecamylamine (0.3, 1.0, and 3.0 mg/kg, s.c.), and saline. All 
rats, regardless of treatment, spent a significantly greater amount of time exploring the novel 
object during the test trial. These results call into question the role of nAChR activity novel 
object recognition acquisition processes. As previously mentioned, several studies show 
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discrepancies between the effects of nicotinic agonists and antagonists in memory formation. 
This topic will be further examined in the discussion section (Besheer, 2001). 
Summary of Modification to the Cholinergic System that Disrupt Memory Processes 
Blocking ACh receptors and obliteration of cholinergic cells have been shown to 
produce deficits in memory acquisition processes, while augmenting the cholinergic system 
with agonists has been shown to facilitate these processes (Table 1).  While these studies 
provide a definitive role for ACh in memory formation, the underlying cellular mechanism 
by which ACh exerts its effect remains unclear.  
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Table 1: Summary of the effects of cholinergic modifications on memory processes 
Behavioral  test Type of memory 
tested 
Modification Drug Results 
MWM Spatial Memory Cholinergic 
lesioning 






MWM Spatial Memory mAChR 
antagonist  








MWM Spatial Memory CNS nAChR 
antagonist  
Mecamylamine i.p. acquisition 
disrupted, retrieval 
intact 













NOR Recognition + 
Location 





















NOR Object Location Cholinergic 
lesioning 


































nAChR antagonist mecamylamine acquisition 
disrupted 
Hp-c., hippocampal cannula; PRh-c, perirhinal cannula; MS-c, Medial Septum cannula i.p., intraperitoneal; 
i.c.v., intracerebroventricular; s.c., subcutaneous 
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The Mechanisms by Which Acetylcholine Modulates Memory Formation 
The exact mechanism by which the cholinergic system modulates hippocampus 
dependent memory acquisition is extremely complex. So far two approaches have been 
employed in order to understand how this system functions. The older, more common 
approach, relies on data obtained from patch-clamp studies investigating the effects of ACh 
agonists and antagonists on various hippocampal neurons. In recent years, the data obtained 
from these patch-clamp studies has been compiled and analyzed using computational models 
in order to create a more complete schematic of the cholinergic systems. While a conclusive 
mechanism remains to be seen, the general mechanism is thought to be as follows:  
During the learning process, previous associations need to be curtailed so that  new 
information can be successfully be processed. For example, take a version of the paired 
association task in which a participant is first asked to remember an association between the 
words “boot” and “leather”. As the words are repeated together several times Hebbian 
consolidation occurs, meaning that if participant is presented with one of the words, their 
neural network will now automatically recall the other word as well. If the participant is then 
asked to remember an association between the words “leather” and “holster” they are 
presented with a problem, as the previous association has been engrained in their memory.  
In order to combat this problem, the brain is able to temporarily inhibit the retrieval of the 
previously made association using proactive interference, as to more efficiently learn the new 
association (Easton, 2012).  
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The “Encoding Versus Retrieval Scheduling” (ERS) Framework Model 
The “encoding versus retrieval scheduling” (ERS) framework is a model that was 
created to ascertain how the hippocampus switches between modes of information encoding 
and retrieving. The idea that ACh levels play a crucial role in determining which mode 
dominates is central to the ERS model. During low levels of cholinergic activation, 
projections from areas of long term memory provide the main source of input to the 
hippocampus. Conversely, high levels of cholinergic activation allow for new associations to 
be formed. Elevated levels of acetylcholine are thought to facilitate the formation of novel 
associations by both reducing interference from cortical regions associated with long term 
memories, and enhancing signal transmission from afferent pathways (Hasselmo,1995 & 
Hasselmo, 2006).  
Low Levels of ACh Set the Stage for Consolidation and Retrieval 
According to the ERS model, consolidation and retrieval processes dominate during 
periods of low ACh levels. Hippocampal consolidation is particularly well studied during 
sleep. Several studies have implicated sharp wave / ripple (SWR) events as playing an 
important role in these consolidation process. SWRs are the most synchronous pattern of 
neuronal discharge observed in the hippocampus. They appear in EEG recordings as high 
frequency oscillations that last for only a few milliseconds (Ylinen, 1995). SWRs most 
frequently occur during slow-wave sleep (SWS) when ACh levels are low. While SWRs also 
occur during learning tasks, they are generally less frequent, and are seldom observed during 
REM sleep (Jadhav, 2012).  
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There are two stages of hippocampus-dependent memory formation. First, the 
hippocampus rapidly encodes information as SWR patterns during alert periods where 
learning is taking place. EEG recordings of CA1 and CA3 in rats show that clusters of 
neurons display SWR patterns during exploration of a novel environment.  These patterns of 
activation could form the basis of memory encoding. Reactivation of the previously encoded 
patterns occur during sleep, actively strengthening the newly encoded memories (O’Neill, 
2010 & Sutherland 2000).  
EEG studies indicate that there is an increase in SWR activity during SWS following 
learning events. In one experiment, rats participated in a training session during which they 
learned to associate a odor with a food reward. EEG recordings were taken during night 
following training. As expected, the rats that learned to associate the odor with the reward 
showed significant amounts of SWR activity during SWS, while those who did not form the 
association did not show elevated levels of SWR activity (Eschenko, 2008). The same pattern 
of neuronal firing has also been shown for associative learning of spatial discrimination 
(Ramadan, 2009). 
Using the drug physostigmine, an acetylcholinesterase inhibitor, it has been proven 
that low levels of ACh are crucial for sleep enabled memory consolidation. During SWS, 
excitatory feedback synapses in CA3 are suppressed by low levels of ACh activity. 
Normally, recurrent connections between CA1 and CA3, as well as between the 
hippocampus and entorhinal cortex, allow for reactivation of SWR patterns of recently 
learned associations. Reactivation of these patterns allow for consolidation and therefore LTP 
to take place (Power, 2004). In an experiment performed by Gais and colleagues in 2003, 
human participants showed enhanced memory formation for both declarative and procedural 
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memory tasks following a full night’s sleep. However, upon receiving a dose of 
physostigmine before going to sleep, the participants did not benefit from sleep induced 
declarative memory consolidation, suggesting that low levels of ACh are critical for memory 
consolidation processes (Gais, 2003).  Administering physostigamine before sleep effectively 
raises ACh levels, therefore suppressing activation of SWS recurrent connections in the 
hippocampus which prevents consolidation facilitated LTP from occurring.  
Recurrent Connections Regulate Hippocampal Activity 
As previously mentioned, the ERS model dictates that low ACh levels direct the 
hippocampus towards consolidation and retrieval processes while high ACh levels prompt it 
to encode new memories. As seen on page 59, scopolamine impairs acquisition but leaves 
retrieval / consolidation intact, indicating that high levels of ACh are required for acquisition 
and not consolidation (Riekkinen, 1997 & Dodart, 1997 ).  
One way in which elevated levels of ACh are able gear the hippocampus towards 
encoding new memories is through the selective activation of recurrent connections. 
Recurrent connections are found in several brain areas including the olfactory cortex, 
neocortex, and hippocampus. For the most part, it is thought that these recurrent connections 
consist of interneuron whose primary function is to modulate activation levels within the 
areas that they innervate (Douglas, 1990). Depending on the location and neurotransmitter 
profile of these interneurons, they are able perform a variety of tasks such as limiting 
feedback within the circuit or strengthen previously learned associations through the 
enhancement of previously formed synapses (Hasselmo, 1994). 
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There are several mechanisms by which ACh is able to suppress feedback within the 
hippocampus. Isolated slice preparations have been used to demonstrate the effects of ACh 
on various layers of the hippocampus. For example, ACh agonists have very little effect on 
excitatory transmission from the entorhinal inputs to the molecular layer of the dentate gyrus, 
while simultaneously suppressing excitatory transmission on the Schaffer collateral inputs in 
CA1. These agonists also suppress excitatory recurrent connections in the stratum radiatum 
of CA3, further limiting internal feedback (Hasselmo, 2004). 
Using a patch-clamp technique it has been shown that nAChR activation by both non-
selective ACh, and selective nAChR agonists results in the depolarization of GABAergic 
interneurons in CA1 (Albuquerque, 2001). Due to the large amount of recurrent connections 
within the interneuron circuitry, this increased GABA release is thought to reduce feedback 
within the hippocampus, allowing it to focus on novel information arriving at the pyramidal 
cells. (Hasselmo, 2004). Similar patterns of suppression have been demonstrated in 
intracortical synaptic transmission in the primary visual cortex as well as the frontal cortex 
(Vidal, 1993). Furthermore, ACh is able to suppress excitatory feedback but not afferent 
olfactory input to the piriform cortex (Hasselmo, 1992) 
Enhancement of Excitatory Transmission From Afferent Inputs  
As previously mentioned, behavioral data shows that cholinergic agonists, nicotine in 
particular, are able to enhance hippocampal-dependent learning. Giocomo and colleagues 
have shown that nicotine is able to selectively enhance afferent input to the hippocampus. In 
their experiments, unipolar stimulating and recording electrodes were placed in several areas 
of hippocampal brain slices extracted from male Sprague-Dawley rats. Electrodes were 
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placed in the Stratum radiatum (SR) to record the evoked synaptic potentials of recurrent 
connections; interneurons of the SR are primarily GABAergic and express α4, α5, α7, and 
β2 nAChR subunits (Liu, 1996). Electrodes were also placed in the striatum lacunosum-
molecular (SLM) to record the evoked postsynaptic potentials of afferent connections. Since 
projections from entorhinal cortex, thalamus, amygdala, and inferotemporal cortex converge 
in the SLM, it is thought to be an important center of integration. Afferent projections from 
the entorhinal cortex terminate in the SLM of CA3 where they synapse primarily with 
pyramidal cells (Capogna, 2011).  
In order to visualize the role of nicotine on these connections, the difference in 
excitatory postsynaptic potential (EPSP) measurements were taken before and after the slices 
were bathed in nicotine. If increasing the level of cholinergic activity resulted in an increase 
in SLM activity, it could be inferred that nicotine helps facilitate memory formation by 
enhancing the input of sensory information to the hippocampus. Their results show that 
nicotine administration did not cause any change in ESPS measurements for the SR, while 
causing SLM transmission to undergo a brief suppression followed by a long-lasting 
enhancement of synaptic transmission. These results suggest that one way in which nicotine 
is able to facilitate learning is by selectively enhancing afferent synaptic transmission, 
therefore allowing the individual to focus on outside stimuli (Giocomo, 2005). As mentioned 
on page 15, periods of enhanced synaptic transmission make neurons more likely to be 
activated together in the future, in a process known as long term potentiation.  
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Alzheimer’s Disease 
As illustrated in the sections above, the cholinergic system plays a complex role in 
learning and memory. That being said, it should come as no surprise that cholinergic 
dysfunction causes a wide range of adverse effects. In fact, cholinergic dysfunction is a 
hallmark of Alzheimer’s Disease, one of the most prevalent neurodegenerative disorders. 
Alzheimer’s Disease (AD) is the most common form of dementia, accounting for 50-
80% of all cases, and is the 6th leading cause of death in the United States. The Alzheimer’s 
Association uses seven “stages” to describe the decline in cognitive function a patient 
experiences during disease progression. During the early stages of AD, the patient may start 
to notice a decline cognitive functions, such as forgetting where they placed their keys. These 
changes, however, may simply be a function of the normal aging process rather than the 
onset of AD and often do not cause suspicion during routine medical examinations. As 
disease progression continues, changes in cognitive function become more apparent. 
Common symptoms include difficulty recalling the name of ordinary objects, committing the 
names of new people to memory, and misplacing objects become common place in everyday 
life. In addition, patients start to have difficulty with arithmetic, such as figuring out tip on 
dinner bills and balancing a check book. As the disease progresses, lapses in memory are no 
longer limited to recent events as memories of earlier life start to fade away. Changes in 
mood are common as a patient may become agitated or withdrawn upon forgetting common 
events in social situations. During moderate or mid-stage AD, patients may start to require 
assistance for everyday life. They may have trouble remembering their own phone number or 
address, become easily confused as to what day of the week it is or where they are, and 
exhibit changes in sleeping patterns. Increased supervision is needed as daily tasks, such as 
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operating the toilet and preparing meals, become more difficult. Eventually larger deficits in 
memory such as forget the names of family members and large portions of their personal 
histories become common. Often times these changes are accompanied delusions and 
obsessive compulsive behaviors. As they progress into severe or late-stage AD, patients are 
unable to carry on a conversation and control muscle movements, making it increasingly 
difficult to sit up write, smiling, or swallowing, and simple reflexes are no longer functional 
(Alzheimer’s Association, 2012). 
Diagnosing Alzheimer’s Disease 
A definitive diagnosis of AD relies on the presence of amyloid plaques and 
neurofibrillary tangles during a postmortem examination (Shen, 2004). The highest 
concentration of plaques and tangles are usually observed in brain areas that rely on 
neurotransmitter acetylcholine (ACh) for communication, such as the hippocampus and 
medial septum (Marco-Contelles, 2006). Deficits in ACh are seen in all patents with AD and 
are often times the first manifestations to appear. Many researchers believe that this 
cholinergic dysfunction, dubbed “the cholinergic hypothesis” may instigate the degradation 
of others (Zamani, 2001).  
The Cholinergic System in Alzheimer’s Disease 
Cholinergic dysfunction may account for many of the cognitive deficits observed in 
patients suffering from AD due to its involvement in learning and memory processes. While 
there are several treatment options aimed at ameliorating the symptoms, there is no known 
cure for AD. All of the treatment options currently approved by the FDA belong to a class of 
drug known as acetylcholinesterase inhibitors (AChEIs). AChEIs impede the natural 
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enzymatic degradation of ACh by acetylcholinesterase in the synaptic cleft, allowing ACh to 
elicit a greater response (Mattson, 2004).  
Although the majority of AD cases are sporadic, studies suggest genetic 
predispositions may play a role in instigating cholinergic dysfunction. For example, 
individuals with certain polymorphisms of the apolipoprotein E (ApoE) allele may be at 
higher risk for developing AD (Kita, 2012).  
The Amyloid Hypothesis  
As previously mentioned, one of the main hallmarks of AD is the appearance of 
amyloid plaques. These plaques are primarily composed of aggregated 40-42 amino acid 
polypeptide chains, Amyloid-β (Aβ). Aβ polypeptides are formed as a result of proteolytic 
cleavage of a type 1 transmembrane protein, Amoloid-β Precursor Protein (APP). In normal 
cellular function, APP is thought to act as a trophic factor as well as play a role in cell 
recognition and adhesion. Once synthesized, APP is transported to the cell membrane where 
it is subject to proteolytic processing by α, β, and γ-secretases, resulting in the formation of 
several Aβ isoforms (Schroder, 1994). In addition the APP isoforms there are also several 
APP-like proteins which are capable of activating the same biochemical pathways resulting 
in similar cellular activities (Heber, 2000).  
The APP molecule itself has extracellular cleavage sites for α-secretases and β-
secretases (BASE), and transmembrane cleavage sites for γ-secretases. If APP is first cleaved 
by BASE, the remaining transmembrane portion is able to undergo cleavage by γ-secretase 
resulting in the formation of Aβ. However, if APP is first processed by α-secretase, BASE 
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cleavage is inhibited, and subsequent cleavage by γ-secretase will not produce Aβ and will 
therefore not generate amyloid plaques (Esler, 2001).  
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peptides in a !-secretase–like manner (23),
there is very little of this protease in the brain,
suggesting that it may play little, if any, role
in the formation of cerebral plaques seen in
AD. Instead, the AD associated with Down
syndrome is probably due to the presence of
an extra copy of the APP gene, which is also
located on chromosome 21.
Several inhibitors of !-secretase activity
have been designed from the !-site in APP
and contain a moiety that mimics the transi-
tion state of aspartyl protease catalysis (13,
24). The bilobal crystal structure of !-secre-
tase bound to one of these compounds at 1.9
Å resolution (25) displays the conserved gen-
eral folding of aspartyl proteases. The inhib-
itor is located in the substrate-binding cleft
between the lobes, with the transition-state
mimicking moiety interacting with the two
active site aspartates. As with other aspartyl
proteases, !-secretase has a “flap” that par-
tially covers the cleft, and the backbone of the
inhibitor is mostly in an extended conforma-
tion. Moreover, most of the hydrogen bond
interactions between the enzyme and the
backbone of the inhibitor are highly con-
served among eukaryotic and HIV aspartyl
proteases. But !-secretase does display some
structural differences with other aspartyl pro-
teases. The !-secretase active site is more
accessible than that of pepsin; in particular,
the S2 and S4 subsites are relatively hydro-
philic and open to solvent. The hydrophilic
character of these subsites is not conserved in
the corresponding subsites of other human
aspartyl proteases, suggesting that these dif-
ferences could be exploited for the design of
selective inhibitors. In contrast, the P3" and
P4" inhibitor side chains point toward the
molecular surface and have little interaction
with the protease, and the backbone of resi-
dues P2" to P4" deviates from the regular
extended conformation, with a kink at P2".
This is also an unusual feature for an aspartyl
protease and might be turned to advantage in
designing !-secretase inhibitors.
!-Secretase appears to be an optimal ther-
apeutic target for the prevention and treat-
ment of AD: The protease catalyzes the initial
step in A! production, A! is strongly impli-
cated in the pathogenesis of the disease, and
the recently solved structure of the enzyme-
inhibitor complex allows structure-based de-
sign. Still, significant hurdles remain before
the development of useful therapies. For
agents to work effectively in vivo, the com-
pounds must not only cross the blood-brain
barrier, but they must also be taken up by
cells. As they must work inside the cell, these
agents should be highly selective: Interfer-
ence with other intracellular proteases and
critical signaling pathways must be mini-
mized. Another concern is that !-secretase
may process substrates in addition to APP.
Given that other membrane secretases, such
as tumor necrosis factor–# (TNF-#) convert-
ing enzyme or TACE (26), have multiple
substrates, !-secretase may likewise cleave
other membrane proteins. The development
of !-secretase knockout mice has so far not
answered this question, because these mice
have no phenotype except for a dramatic
reduction in A! levels (27, 28). The lack of
phenotype in the BACE knockout mice sug-
gests that blocking !-secretase pharmacolog-
ically should effectively lower A! with min-
imal side effects. But even if it does turn out
that !-secretase is an important player in
normal adult physiology, only partial inhibi-
tion may be needed for a therapeutic effect.
Another key unknown is the function of
BACE2. This enzyme is strongly expressed
in heart, kidney, and placenta, suggesting that
it may be important in highly vascularized
systemic tissues (23). If so, it will be critical
to develop drugs that selectively block BACE
but not BACE2. Mice deficient in BACE2
should provide critical clues to this important
question.
!-Secretase: A Familiar
Metalloprotease Intersects with APP
and Notch
Alternative processing of APP by #-secretase
precludes A! production, as this enzyme
cleaves within the A! sequence (29, 30).
Although cells contain a certain level of basal
#-secretase activity, proteolysis by this en-
zyme can be increased by activators of pro-
tein kinase C (PKC), such as phorbol esters
(31–34). Moreover, activation of receptors
that work through PKC can augment #-secre-
tase cleavage of APP with concomitant re-
duction in !-secretase processing. For in-
stance, agonists of the metabotropic gluta-
mate receptors can lower A! by shunting
APP toward the #-secretase pathway (35).
Muscarinic agonists (M1 and M3) can like-
wise decrease A! production, and this effect
has been observed in vitro as well as in vivo
(31, 36–39). Because of this effect on A!
production, M1 and M3 agonists might be
useful agents for treating AD. In addition,
experimental evidence suggests that APPs
may have a neuroprotective effect and may
enhance learning and cognition (40); thus,
augmenting #-secretase processing of APP to
release APPs might be beneficial in treating
AD.
The principal determinants of APP cleav-
age by #-secretase appear to be the distance
of the hydrolyzed bond from the membrane
(12 or 13 residues) and a local helical con-
formation (41). Pharmacologic studies initial-
ly suggested that #-secretase might be a zinc-
dependent metalloprotease, because its activ-
ity can be blocked by peptide hydroxamates
Fig. 1. APP and Notch processing. (A) APP can
be cleaved sequentially by !-secretase (BACE)
and $-secretase—a protease complex contain-
ing presenilin (PS) as the putative catalytic
component—to produce A!. (B) Alternatively,
APP can be processed by #-secretase and
$-secretase to produce P3. TACE and ADAM10
appear to be among the #-secretases. (C) Upon
ligand activation, Notch is also processed se-
quentially, apparently by TACE and a PS-depen-
dent $-secretase–like protease to produce
NICD. This liberated cytosolic portion then
translocates to the nucleus and activates tran-
scription factors.
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peptides in a !-secretase–like manner (23),
there is very little of this protease in the brain,
suggesting that it may play little, if any, role
in the formation of cerebral plaques seen in
AD. Instead, the AD associated with Down
syndrome is probably due to the presence of
an extra copy of the APP gene, which is also
located on chromosome 21.
Several inhibitors of !-secretase activity
have been designed from the !-site in APP
and contain a moiety that mimics the transi-
tion state of aspartyl protease catalysis (13,
24). The bilobal crystal structure of !-secre-
tase bound to one of these compounds at 1.9
Å resolution (25) displays the conserved gen-
eral folding of aspartyl proteases. The inhib-
itor is located in the substrate-binding cleft
between the lobes, with the transition-state
mimicking moiety interacting with the two
active site aspartates. As with other aspartyl
proteases, !-secretase has a “flap” that par-
tially covers the cleft, and the backbone of the
inhibitor is mostly in an extended conforma-
tion. Moreover, most of the hydrogen bond
interactions between the enzyme and the
backbone of the inhibitor are highly con-
served among eukaryotic and HIV aspartyl
proteases. But !-secretase does display some
structural differences with other aspartyl pro-
teases. The !-secretase active site is more
ac es ible than that of pepsin; in particular,
the S2 and S4 subsites are relatively hydro-
philic and open to solvent. The hydrophilic
character of these subsites is not conserved in
the corresponding subsites of other human
aspartyl proteases, suggesting that these dif-
ferences could be exploited for the design of
selective inhibitors. In contrast, the P3" and
P4" inhibitor side chains point toward the
molecular surface and have little interaction
with the protease, and the backbone of resi-
dues P2" to P4" deviates from the regular
extended conformation, with a kink at P2".
This is also an unusual feature for an aspartyl
protease and might be turned to advantage in
designing !-secretase inhibitors.
!-Secretase appears to be an optimal ther-
apeutic target for the prevention and treat-
ment of AD: The protease catalyzes the initial
step in A! production, A! is strongly impli-
cated in the pathogenesis of the disease, and
the recently solved structure of the enzyme-
inhibitor complex allows structure-based de-
sign. Still, significant hurdles remain before
the development of useful therapies. For
agents to work effectively in vivo, the com-
pounds must not only cross the blo d-brain
barrier, but they must also be taken up by
cells. As they must work inside the cell, these
agents should be highly selective: Interfer-
ence with other intracellular proteases and
critical signaling pathways must be mini-
mized. Another concern is that !-secretase
may process substrates in addition to APP.
Given that other membrane secretases, such
as tumor necrosis factor–# (TNF-#) convert-
ing enzyme or TACE (26), have multiple
substrates, !-secretase may likewise cleave
other membrane proteins. The development
of !-secretase knockout mice has so far not
answered this question, because these mice
have no phenotype except for a dramatic
reduction in A! levels (27, 28). The lack of
phenotype in the BACE knockout mice sug-
gests that blocking !-secretase pharmacolog-
ically should effectively lower A! with min-
imal side effects. But even if it does turn out
that !-secretase is an important player in
normal adult physiology, only partial inhibi-
tion may be needed for a therapeutic effect.
Another key unknown is the function of
BACE2. This enzyme is strongly expressed
in heart, kidney, and placenta, suggesting that
it may be important in highly vascularized
systemic tissues (23). If so, it will be critical
to develop drugs that selectively block BACE
but not BACE2. Mice deficient in BACE2
should provide critical clues to this important
question.
!-Secretase: A Familiar
Metalloprotease Intersects with AP
and Notch
Alternative proces ing of AP by #-secretase
precludes A! production, as this enzyme
cleaves within the A! sequence (29, 30).
Although cells contain a certain level of basal
#-secretase activity, proteolysis by this en-
zyme can be increased by activators of pro-
tein kinase C (PKC), such as phorbol esters
(31–34). Moreover, activation of receptors
that work through PKC can augment #-secre-
tase cleavage of AP with concomitant re-
duction in !-secretase proces ing. For in-
stance, agonists of the metabotropic gluta-
mate receptors can lower A! by shunting
AP toward the #-secretase pathway (35).
Muscarinic agonists (M1 and M3) can like-
wise decrease A! production, and this ef ect
has be n observed in vitro as well as in vivo
(31, 36–39). Because of this ef ect on A!
production, M1 and M3 agonists might be
useful agents for treating AD. In ad ition,
experimental evidence sug ests that AP s
may have a neuroprotective ef ect and may
enhance learning and cognition (40); thus,
augmenting #-secretase proces ing of AP to
release AP s might be beneficial in treating
AD.
The principal determinants of AP cleav-
age by #-secretase ap ear to be the distance
of the hydrolyzed bond from the membrane
(12 or 13 residues) and a local helical con-
formation (41). Pharmacologic studies initial-
ly suggested that #-secretase might be a zinc-
dependent metalloprotease, because its activ-
ity can be blocked by peptide hydroxamates
Fig. 1. AP and Notch processing. (A) AP can
be cleaved sequentially by !-secretase (BACE)
and $-secretase—a protease complex contain-
ing presenilin (PS) as the putative catalytic
component—to produce A!. (B) Alternatively,
AP can be processed by #-secretase and
$-secretase to produce P3. TACE and ADAM10
ap ear to be among the #-secretases. (C) Upon
ligand activation, Notch is also processed se-
quentially, ap arently by TACE and a PS-depen-
dent $-secretase–like protease to produce
NICD. This liberated cytosolic portion then
translocates to the nucleus and activates tran-
scription factors.
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Fu l length APP processing by α, β, and γ-secretases (a) initial processing by β-secretase 
allows for subsequent processing by  γ-secretase, resulting in the formation of Aβ. (b) initial 
processing by α-secretase inhibits β-secretase cleavage. No Aβ is produced upon further 
pro essing by  γ- ecretase, pr luding the formation of Aβ. (Adapted from Esler, 2001) 
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  In healthy individuals the majority of the Aβ peptides produced are 40 amino acids in 
length (Aβ40). The Aβ40 are readily digested within the cellular environment and therefore 
are not thought to cause any negative effects. While infrequent, the synthesis of a more 
hydrophobic, 42 amino acid polypeptide (Aβ42) is also possible in healthy individuals. In 
AD, alternative processing of APP results in the formation of large amounts of (Aβ42) 
(Kamenetz, 2003 & Jackish, 2009). Once synthesized, the Aβ42 peptide exists in an 
equilibrium of conformational states. Aβ42 is able to fold into α-helical monomers or β-sheet 
structures. The α-helical monomers are soluble and therefore pose very little threat to the 
human brain, while the β-sheets can be more problematic. As the β-sheets are formed, they 
aggregate, becoming oligomeric. When enough of the aggregate form is present, it 
precipitates out as neurotoxic amyloid plaques and is unable to reassume the soluble α-
helical form (Zeng, 2001). Additionally there are several complex molecules which 
coordinate the binding of Cu2+, Fe2+, and Zn2+ to Aβ, inducing it to assume the β-sheet 
conformation (Bossy-Wetzel, 2004). Recent research has shown that nicotine may regulate 
metal ion homeostasis thereby attenuating Aβ neurotoxicity, making nicotine administration 
a possible treatment strategy for AD (Zhang, 2006). 
Determination as to which Aβ is produced seems to be largely controlled by a 
complex consisting of several proteins, γ-secretase. One sub-complex, the presenilin (PS) 
family of proteins, is responsible for providing catalytic energy necessary for cleavage of 
APP. Included in the PS family is presenilin 1 (PS1), located on chromosome 14, and 
presenilin 2 (PS2), located on chromosome 1(Van Broeckhoven, 1995). Mutations in PS1 
and PS2, as well as in the APP gene itself, change the way that APP is processed and cause 
increased Aβ42 metabolism. Neuronal activity itself is also able to regulate both the 
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production and secretion of Aβ through γ-secretase mediated processing of APP. Research 
shows that an increase neuronal activity causes an increase in Aβ formation. Consequently, 
this  increase in Aβ formation causes a depression in synaptic activity suggesting that Aβ 
generation may be implicated in regulating neuronal excitability (Kamenetz, 2003).  
The exact mechanism by which Aβ plaque deposition leads to neural toxicity is not 
fully understood, however several explanations have been proposed. First, it has been shown 
that soluble Aβ is able insert itself into cell membranes, increasing their fluidity. Many 
membrane bound proteins rely on specific membrane fluidities to function properly, 
especially in synaptic membranes, therefore a disruption in membrane fluidity caused by Aβ 
may result in neural dysfunction (Avdulov, 1997). Additionally, the formation of Aβ plaques 
generates free radicals (Hensley, 1994). These free radicals then interact with membrane 
bound fatty acids, producing a variety of aldehydes such as 4-hydroxynoneal (HNE). Upon 
exposure to HNE, cultured hippocampal cells undergo neurite fragmentation and cell body 
vacuolation, common in neuron degeneration (Mark, 1997).   
Treatment Options  
Early pharmacological treatments of AD included administration of acetylcholine 
precursor molecules, muscarinic and nicotinic agonists. The administration choline in hopes 
of stimulating ACh production proved ineffective and caused several adverse side effects. 
The use of mAChR agonists was also ineffective due to their low bioavailability and receptor 
subtype specificity, as well as the high rate of side effects. Conversely, stimulating nAChRs 
resulted in improved cognitive function and was fairly well tolerated. There are inherent 
problems associated with the used of nAChR agonists such as difficulty targeting CNS while 
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leaving the periphery unaffected, and selectively activating specific receptor subtypes. 
Furthermore, nAChRs become desensitized upon constant stimulation, making nAChR 
agonists ineffective after a short period of time (Farlow, 2001).  
All of the drug treatments currently approved by the FDA to treat AD – Cognex, 
Donepezil, Rivastigmine, and Galantamine – are acetylcholinesterase inhibitors (AChEIs.) 
Shortly after ACh is released into the synaptic cleft it is captured by the protease, 
acetylcholinesterase (AChE), which hydrolyzes its ester bond liberating choline and acetate. 
Although it is less abundant, the protease, butyrylcholinesterase (BuChE), is also able to 
degrade ACh by hydrolyzing its ester bond (Darvesh, 2002). By inhibiting the natural 
degradation of ACh by AChE they are able to help alleviate some of the cognitive deficits 
caused by cholinergic neurodegeneration. These drugs only offer symptomatic relief, as they 
are unable to stop, slow, or reverse the degradation of cholinergic neurons. Furthermore, the 
use of AChEIs usually becomes ineffective within a year due to the progressive nature of 
neurodegeneration found in AD (Michaelis, 2003). Acquiring a more complete view of how 
the cholinergic system influences memory is the first step in creating drugs that will, some 
day, more effectively treat or even cure AD. 
 
Summary 
Based on previous research and the information provided above, it is thought that  
nicotinic stimulation of the cholinergic system may facilitate memory acquisition processes 
related to object recognition. In order to test this hypothesis, we employed a NOR test during 
which rats received an injection of nicotine after the familiarization trial. We expect that rats 
treated with nicotine will spend a greater proportion of time investigating the novel object 
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during the test trial than those treated with saline. Immunohistochemistry will then be used to 
analyze the effects of nicotine on a cellular level. We expect that there will be an increase in 
c-Fos expression, the gold standard for measuring neuronal activation, in the hippocampus 
and PRh, two areas commonly associated with object recognition. Furthermore, since ACh is 
thought to play an important role in memory formation we expect to see a high level of 
ChAT expression in the medial septum, the main source of ACh to the hippocampus, in rats 
treated with nicotine.  
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Methods 
Subjects and Drug Administration 
 The subjects for this experiment were twelve male rats, of the genus Rattus and 
species norwegicus, from the Sprague-Dawley strain. They were provided from Charles 
River Labs, and had no prior experience with experiments of this kind. At the time of testing 
the rats were approximately four months old and weighed between 368g and 471g. They 
were housed in same sex pairs, in a temperature controlled room kept on a 12 hour light 
cycle, and given free access to food and water. The subjects were randomly divided into 
either the control or treatment group, and received an i.p. injection of saline or 0.3mg/kg 
nicotine tartrate, respectively. The researchers were kept blinded to prevent any bias. 
Approximately two hours after injection, carbon dioxide was used to sacrifice the animals. 
The procedures used in this project were approved by the Connecticut College Animal Care 
and Use Committee, in accordance with guidelines provided by the Guide for the Care and 
Use of Laboratory Animals. 
Materials 
Nicotine tartrate was obtained from Sigma-Aldrich, and administered as a 0.3 mg/ml 
solution in saline. The objects used in the test were attached to the top of small glass jars, 
which could be secured to the floor of the novel object recognition box. Three objects of 
similar dimensions were used: a yellow cylindrical block, a blue triangular wooden block, 
and a red wooden block. Which objects were used for the familiarization and test trials were 
systematically alternated to prevent any object bias. A video camera with and ANY-maze 
software was used to record the videos for later analysis.  
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The subjects were sacrificed using carbon dioxide gas, and immediately perfuse using 
a 0.1M phosphate buffer solution (PB) along with an injection of heparin, then with a 4% 
paraformaldehyde solution. The brains were then extracted and stored in a 30% solution of 
sucrose containing sodium azide and stored in a refrigerator until being sliced with a cryostat. 
Immunohistochemistry was performed using Santacruz Biotech and Jackson 
ImmunoResearch reagents. The samples were individually stained using c-Fos and ChAT 
primary antibodies, then goat anti-rabbit polyclonal biotinylated secondary antibodies, 
followed by ABC/DAB detection kit. The results were visualized using an Olympus BX41 
microscope and quantified using IPLab software.  
Procedure 
All twelve rats were handled several times in the weeks prior to testing in order to 
familiarize them with human interaction. Twenty-four hours prior to testing, the rats were 
placed in the novel object recognition box (NORbox) for five minutes without any objects as 
to prevent any novelty bias on test day. On the morning of test day, the 0.3mg/kg nicotine in 
saline solution test solution and the control saline solution were prepared by a third party, 
placed in vials labeled “A” and “B”, and given to the researcher administering the test, as to 
not introduce any biases. The rats were then randomly assigned to a treatment group.  During 
the familiarization trial (FT) each rat spent five minutes in the NORbox with two objects 
located in opposite corners. The locations and the identities of the objects were 
systematically arranged so that every combination of object and location was possible during 
the FT and the test trial (TT). Immediately after completion of the FT, the rats were given an 
1ml/kg intraperitoneal injection of the appropriate solution, and placed back in their original 
cages for eighty-five minutes.  
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 During the test trial one of the familiar objects was replaced with the other novel 
object according to the systematic plan. The rats were then placed back in the NORbox for 
the TT, which also lasted 5 minutes. Both the FT and TT trial were recorded using a video 
camera and recorded for later analysis. 
 The rats were sacrificed immediately after the TT using a carbon dioxide chamber. 
They then received an injection of heparin directly into their hearts to thin their blood for 
perfusion. In order to clear all blood from the tissue, the rats were then perfused using a 0.1M 
solution of PB. Next, the rats were perfused with a 4%  paraformaldehyde solution in order to 
prevent tissue degradation. The brains were extracted and stored in a 4% paraformaldehyde 
solution for twelve hours before being transferred into a 30% sucrose solution containing 
sodium azide and stored in a refrigerator until slicing. 
 Prior to slicing, the brains were rinsed in phosphate buffer solution to remove any 
paraformaldehyde present and a block was used to isolate a segment of the brain located 
between the optic chiasm and the end of the hippocampus. Approximately 200, 40 micron 
segments were taken from each brain using a cryostat. The samples were stored  in 
cryoprotectant  and refrigerated until staining. 
 A set of three slices were selected from approximately the same region of both the 
hippocampus and medial septum (MS) for staining. All tissue samples were first stained for 
c-Fos expression using a rabbit anti-Fos polyclonal IgG primary antibody from Santacruz 
Biotech. The primary c-Fos antibody was prepared in a 1:8000 ratio with 50ml blocking 
solution (0.01MPBS, normal goat serum, fetal bovine serum, and 30% 100x Triton).  All 
tissue was first washed three times in 0.01M PBS for ten minutes, and then placed in the c-
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Fos primary antibody overnight. Twenty-four hours later, both sets of tissue were washed for 
ten minutes in 0.01M PBS, three times to remove the primary antibody. Both sets of tissue 
were placed in the same, 1:200 solution of biotinylated goat anti-rabbit polyclonal IgG 
secondary antibody from Jackson Laboratories in 50ml blocking solution, for two hours. The 
tissue was washed for ten minutes in 0.01M PBS, three times to remove the secondary 
antibody and placed in Avidin-Biotin complexed solution with horseradish peroxidase from 
an ABC detection kit by Vectastain, for one hour. The  tissue was then washed for ten 
minutes in 0.01M phosphate buffer, three times to remove the ABC solution. The tissue was 
then placed in an enhanced diaminobenzidine (DAB) solution for eight minutes (25μL 
glucose oxidase, 800μL nickel ammonium sulfate soln., 500μL cobalt chloride soln., 20μL 
ammonium chloride, 10mg DAB, 20mg beta-D-glucose, in 50mL 0.1M PB). Both sets of 
tissue were washed for ten minutes in 0.01M PBS, three times to remove the DAB solution. 
The hippocampal slices were mounted onto slides and left to dry for two days, while the MS 
slices were placed in ChAT primary antibody over night. The primary ChAT rabbit anti-Fos 
polyclonal IgG primary antibody was obtained from Millipore and prepared in a 1:5000 ratio 
with 50ml blocking solution. The next day, the tissue was washed for ten minutes in 0.01M 
PBS, three times to remove the primary antibody.  Next the tissue was placed in a 1:200 
solution of biotinylated goat anti-rabbit polyclonal IgG secondary antibody for two hours. 
The secondary antibody was removed by washing the tissue three times for ten minutes in 
0.01M PBS. The tissue was then placed in Avidin-Biotin complexed solution with 
horseradish peroxidase from an ABC detection kit by Vectastain, for one hour. The ABC 
solution was removed by washing the tissue for ten minutes in 0.01M phosphate buffer, three 
times. In order to create a discernable difference between the c-Fos and ChAT staining, the 
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tissue was incubated in a non-enhanced diaminobenzidine (DAB) solution for six minutes 
(25υL glucose oxidase, 10mg DAB, 20mg beta-D-glucose, in 50mL 01M PB). The tissue 
was then washed three times, for ten minutes, in 0.01M PBS, and then mounted onto slides. 
The slides were then placed with their hippocampal counterparts and left to dry overnight. 
The following day all of the slides were rinsed in a graded ethanol wash (50%, 75%, 90%, 
95%, and 100%) followed by a clearing solution before being cover-slipped using Permount.  
 The activated c-Fos particles in the DG, CA1, CA3, and PRh regions were examined 
using an Olympus BX41 microscope at 10x magnification. A template for each brain region 
was made using a stereotaxic atlas to delineate the boarders and kept constant across animals. 
The hippocampus and perirhinal cortex were -3.30mm from bregma, and the medial septum 
was 1.00mm from bregma  (Paxinos, 2007). Once a template had been obtained the number 
of cells expressing activated c-Fos particles were counted by hand by an observer blinded to 
treatment. Only the darkest stained cells were counted as expressing c-Fos particles. The 
cells dual labeled for c-Fos / ChAT in the medial septum were quantified using the same 
technique. Only cells stained for both c-Fos and ChAT were counted. Two of the most 
evenly stained tissue samples from each animal were selected for data analysis. The number 
of cells expressing the various immunohistochemical markers were averaged for each animal.  
Analysis 
The videos created during the FT and the TT were analyzed; the average distance 
traveled during each trial was quantified using the ANY-maze software while the number of 
visits to the novel object and the familiar object were recorded by a blinded observer. A visit 
was defined as anytime a rat had his nose touching, or within 0.5 cm of an object. In addition 
to the number of visits to each object, a difference score was created in order to account for 
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individual variations in exploration during the test trial: Difference score = (number of visits 
to the novel object) – (number of visits to the familiar object). The amount of c-Fos and 
ChAT expression was counted by a blinded researcher. Three tissue samples were analyzed 
per brain area.  The hippocampal and perirhinal cortex tissue samples each contained two 
brain regions, one left and one right, allowing for two data points per tissue sample. Due to 
the central location of the medial septum, only one data point could be collected per tissue 
sample. Once the samples had been collected the two that exhibited the most even staining 
were analyzed. The results of the immunohistochemistry experiments as well as the 
behavioral results were analyzed using a students t- test and a Pearson correlation test in 
SPSS. In both cases analysis was done using each individual animal’s behavioral and 
immunohistochemical data. 
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Results 
Novel Object Recognition: Behavioral Results 
 
To assess the effects of nicotine on memory formation from a behavioral perspective, 
the number of visits to both objects during familiarization and the test trial were recorded 
both for the nicotine and saline treated rats. This data was considered in multiple forms.  
First, the average number of visits, to both objects, during familiarization and the test trial 
was calculated for each treatment and represented graphically (Figure 16).   
The average number of visits, for both treatment groups combined, to the familiar 
object during familiarization and the test trial was also examined and displayed graphically 
(Figure 17). A students t-test measures revealed that rats explored the familiar object 
significantly fewer times during the test trial (M= 3.75) than the familiarization trial 
(M=6.330) T(22) = 2.1295, P = 0.0450. There was no significant difference present when 
examining the effects of drug treatment on exploration of the familiar object between trials.  
The average number of visits, for both treatment groups combined, to the temporary object 
(the object which was later replaced by the novel object) during familiarization was 
compared to the number of visits to the novel object during the test trial and displayed 
graphically (Figure 18). A students t-test revealed that there was no significant difference 
between the number of visits for each object.  
The effects of drug treatment on average number of visits to the novel and familiar 
objects during the test trial was calculated (Table 2) and represented graphically (Figure 19). 
Upon analysis with a students t-test, it was determined that the effect of drug was not 
significant.  
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In order to account for individual differences in exploration during the test trial we 
computed a difference score for each animal: (number of visits to the novel object) – 
(number of visits to the familiar object), (Figure 20).  Using a students t-test, we determined 
that there was a significant effect of drug treatment on the difference score; rats treated with 
nicotine had a significantly larger difference score (M=2.5) than those treated with saline 
(M=-.33) T(5) = -2.996, P=0.030. Additionally, the average distance traveled by the saline 
and nicotine treatment groups was examined. It was determined that there was no significant 
difference in the average distance that the nicotine and saline treated animals traveled during 
the test trial (Figure 21). 
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Figure 17: Average number of visits, for both treatment groups combined, to the familiar 













*indicates significance at the α=.05 level 
 
Figure 18: Average number of visits, for both treatment groups combined, to the temporary 
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Table 2: Average number of visits to each object during the test trial  
Means and Standard Deviations (N = 12)  
 Familiar Object Novel Object 
Variable Mean SD Mean SD 
Nicotine 3.33 2.50 5.83 3.25 
Saline 4.17 3.54 3.83 2.79 
 
















Figure 20: Average difference in exploration during the test trial 
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Immunohistochemistry:  
 The average number of cells expressing c-Fos within the DG, CA1, and CA3 of the 
hippocampus, as well as the in the PRh, were counted in order to determine the effects of 
nicotine on neuronal activation (Table 3). Analysis using a students t-test revealed that the 
rats treated with nicotine displayed significantly more c-Fos expression in the hippocampus 
and perirhinal cortex combined than those treated with saline, T(86)=1.9965, P=0.0490 
(Figure 22). Nicotine administration resulted in a significant increase of c-Fos expression in 
the hippocampus, T(64)=2.0219, P=0.0474, but not in the perirhinal cortex (Figure 23). 
Additionally, nicotine administration resulted in elevated c-Fos expression within the DG: 
T(20)=3.1943, P=0.005, and CA3: T(20)= -1.525, P=0.005, but not CA1 of the hippocampus 
(Figure 24). 
 The average number of cells in the medial septum (MS) labeled for both c-Fos and 
ChAT was calculated in order to determine the effect of nicotine on the activation of 
cholinergic cells. It was determined using a students t-test that drug treatment did not 
significantly influence the number of cells expressing both c-Fos and ChAT in the MS 
(Figure25). 
 A Pearson correlation was used in order to determine any correlations between the 
behavioral and immunohistological data. The increased the number of cells expressing both 
c-Fos and ChAT in the MS is strongly and positively correlated to the difference in 
exploration during the test trail (r=.840, p=.01). There was no significant correlation between 
the difference score and the c-Fos expression for both treatments in the hippocampus and 
perirhinal cortex. 
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Table 3: c-Fos expression by brain region 
Means and Standard Deviations (N = 12)  
  DG CA1 CA3 HPC PRh 
  Mean SD Mean SD Mean SD Total SD Mean SD 
Nicotine 13.08 2.85 3.25 1.27 4.13 1.00 20.46 4.87 14.25 3.49 
Saline 9.45 2.40 2.50 1.25 2.60 1.31 14.55 3.70 11.35 3.90 
 
Figure 22: Graphical representation of c-Fos expression for the HPC and PRh combined 
  
*indicates significance at the α=.05 level  
 
Figure 23: Graphical representation of c-Fos expression in the hippocampus and PRh 
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Figure 24: Graphical representation of c-Fos expression in the hippocampus by region 
 
*indicates significance at the α=.05 level  
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Discussion 
Behavior 
The hypothesis for this experiment was that nicotinic stimulation of the cholinergic 
system facilitates memory acquisition as related to object recognition. The results of the 
novel object recognition test, as well as the immunohistochemistry study, appear to support 
this hypothesis. Furthermore, these results are consistent with those of other researchers 
demonstrating nicotine facilitated enhancements of memory acquisition processes in NOR 
(Melichercik, 2012). 
The NOR test is a frequently used method of studying hippocampal dependent 
learning based upon the tendency of rats to explore novel objects more than previously 
encountered objects (Broadbent, 2009). A typical NOR test consists of two phases: 
familiarization and test trial. During familiarization, the rats are placed in the NOR apparatus 
for five minutes with two never before encountered objects designated the “temporary 
object” and the “familiar object”. After a predetermined amount of time, the rats are returned 
to the NOR apparatus for a five-minute test trial. During the test trial, the NOR apparatus 
contains the “familiar object” and the “novel object” (replacing the temporary object). Since 
nicotine is thought to facilitate memory acquisition, giving the rats a dose of nicotine shortly 
after the familiarization trial should create a stronger memory as to which object the rats 
previously encountered. Therefore, the rats treated with nicotine should investigate the novel 
object a significantly greater proportion of times than the familiar object.  
The ANY-maze tracking software used to quantify the total distance traveled seemed 
to have some difficulty differentiating between the front and back of the animal. While this 
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problem most likely did not interfere with the validity of the mobility results, it made it 
impossible to quantify the number of visits made to each object using the software provided. 
Consequently, the data for number of visits was calculated manually by a blinded observer 
watching recordings of each familiarization and test session.  
The results of the NOR test help support the hypothesis that acute nicotine 
administration enhances the acquisition of object recognition memory. The drug treatment 
did not produce a significant difference in the total number of visits during a given trial 
(Figure 16). This is a good indication that any novelty result is due to better remembering the 
familiar object and not just a result of increased exploration. In addition, nicotine 
administration did not affect the average distance traveled during the test trial, indicating that 
any nicotine facilitated memory enhancements observed during the test trial were actually 
caused by improved memory formation, and not simply a byproduct of nicotine-induced 
locomotion. The number of total visits to the familiar object decreased significantly between 
the familiarization trial and the test trial. This shows that the rats remembered encountering 
the familiar object from the familiarization trial, and as a result, spent less time investigating 
it during the test trial (Figure 17). While this was expected, it helps confirm the validity of 
our results. There was no significant difference between the number of visits to the 
temporary object during the familiarization trial, and the number of visits to the novel object 
during the test trial (Figure 18).  Since the object location, as well as the particular object 
used for each trial, were rotated between subjects, this is good proof that none of the objects 
or object locations were favored and therefore caused the rats to investigate them more 
thoroughly. 
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Although not statistically significant, the rats in the nicotine group tended to visit the 
novel object more than any other object during the test trial (Figure 19). In order to 
investigate this trend further, a difference score was calculated for each animal: (number of 
visits to the novel object) – (number of visits to the familiar object). The use of a difference 
score has been validated by several researchers (Besheer, 2000 & Hannesson, 2004). It 
allows for a more accurate representation of the drug effect by accounting for individual 
differences in exploration during the test trial (Figure 20). Using the difference score, it was 
determined that the drug treatment had a significant effect; rats treated with nicotine visited 
the novel object significantly more during the test trial than those treated with saline. On 
average, the rats in the nicotine group visited the novel object three more times than the 
familiar object during the test trial, while rats treated with saline visited both objects roughly 
the same.  
Our results, which show that acute nicotine administration facilitates object 
recognition memory acquisition, are consistent with the literature data. Furthermore our 
difference score is comparable to that obtained by Melicherick and colleagues (Melichercik, 
2012). Most, if not all of the behavioral studies mentioned in the introduction, focus only on 
the behavioral changes facilitated by the administration of various drugs without attempting 
to elucidate the underlying neuronal mechanism responsible for these changes. In addition to 
supporting the hypothesis that nicotine stimulation of the cholinergic system facilitates 
memory acquisition, the results of our immunohistochemical study provide insight into the 
neuronal mechanisms responsible for these behavioral changes.  
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Immunohistochemistry   
The intermediate-early gene, c-Fos, is maximally expressed ninety minutes after 
periods of intense neuronal activation, making it the gold standard for measuring neuronal 
activation (Kovacs, 1998 & Worley, 1991). The number of cells expressing c-Fos in the 
hippocampus and perirhinal cortex was combined in order to determine the effect of drug on 
neuronal activation. As expected, nicotine administration caused an overall increase in 
neuronal activation (Figure 22). When the hippocampus and perirhinal cortex were analyzed 
individually, nicotine caused a highly significant increase in c-Fos expression in the 
hippocampus, while only producing a nearly significant increase in the perirhinal cortex. The 
individual regions of the hippocampus were also examined and it was determined that 
nicotine administration caused a significant increase in neuronal activation in dentate gyrus 
(DG) and CA3, but not CA1. These results confirm the literature findings that a nicotine-
facilitated enhancement of acquisition of object recognition memory is a hippocampal 
dependent process. Contrary to these results, some studies show that the hippocampus is 
more involved in object location rather than object recognition processes, while the opposite 
is true for the perirhinal cortex (Mumby, 1992 & Ennaceur, 1996). However, surgically 
disconnecting the hippocampus from the perirhinal cortex causes severe deficits in both 
object location and object recognition processes, demonstrating that communication between 
these two areas is necessary for both forms of memory formation (Warburton, 2003).  
The discrepancy between the literature data and our data may be a result of the NOR 
protocol used in our study.  As demonstrated in figure 7 on page 35, three objects were used 
in our NOR protocol. During familiarization, objects “A” and “B” were placed kitty-corner 
to each other. During the test trial the locations of objects “A” and “B” were swapped and 
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object “B” was replaced by object “C”, thereby making “C” the novel object and “A” the 
familiar object. It is possible that changing the location of object “A” between the 
familiarization trial the test trial could have imparted object location novelty aspects to the 
familiar object, activating the hippocampal dependent spatial memory processes. 
Furthermore, the increased difference score caused by nicotine administration could be 
attributed to a combination of object location and object recognition memory formation. This 
means that object location memory processes could have been activated by both objects “A” 
and “C”, while object recognition memory processes were only activated by object “C” 
during the test trial. This could account for the significant increase in hippocampal activation, 
which is heavily involved in spatial recognition, and the almost significant PRh activation 
that is primarily involved in object recognition memory. It would be beneficial to control for 
object location if this experiment were to be repeated.  
Timing is an important aspect of immunohistochemistry protocol design when 
measuring immediate early gene product expression in order to characterize neuronal 
activation. Several studies indicate that the maximum level of c-Fos expression occurs 
between one and three hours after periods of extended neuronal activation (Kovacs, 1998). 
Further research indicates that c-Fos levels may fluctuate within this two-hour window, with 
absolute maximum expression occurring at ninety minutes (Meyza, 2007). For this reason, 
we attempted to collect tissue samples from each animal approximately ninety minutes after 
drug administration.  
Because the familiarization and test trials were only spaced two hours apart, we 
believe that we are measuring nicotine-facilitated changes in acquisition, rather than 
consolidation memory. This rational is due mainly to the fact that, according to the ERS 
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framework model of hippocampal activity, low levels of cholinergic activity during slow 
wave sleep are thought to set the stage for consolidation (Hasselmo, 2006). However, due to 
a lack of research investigating hippocampal dependent memory acquisition on c-Fos 
expression levels, we are unable to conclusively say that ninety minutes after injection was 
the ideal time to collect tissue. In future studies it would be beneficial to collect tissue at 
fifteen-minute intervals and determine the point at which c-Fos expression is at a maximum. 
This would allow for a more accurate representation of memory acquisition facilitated 
changes in c-Fos expression. 
One of the highest concentrations of cholinergic cells is located in the medial septum 
(MS). As described in the introduction, the medial septum is responsible for sending a large 
amount of information to the DG. It was also hypothesized that nicotine administration 
would selectively increase the level of cholinergic activation in the medial septum (MS), 
since nicotine is an agonist for the cholinergic system and is capable of stimulating the 
release of acetylcholine. Previous research shows that it is possible to label cholinergic cells 
by probing with an antibody specific for choline acetyltransferase (ChAT), the enzyme 
responsible for the biosynthesis of acetylcholine (Armstrong, 1983). It is also possible to 
specifically label cholinergic neurons that have recently undergone a period of increased 
activation by dual staining with both c-Fos and ChAT antibodies (Modirrousta, 2004).  
While the results of the c-Fos / ChAT dual staining show a trend that nicotine 
increases cholinergic activation in the MS, they are not statistically significant. This is most 
likely due to the small sample size. Since the medial septum is located directly in the center 
of the brain, each slide only yields one data set. The hippocampus and perirhinal cortex, on 
the other hand, yields two data sets per slice, one on each side of the brain. While the results 
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of the dual staining were insignificant when viewed alone, it was determined that the trend of 
nicotine facilitated increase in cholinergic activation was strongly correlated to the nicotine 
facilitated increase difference score using a Pearson correlation. This is the first study to 
physically link cholinergic activation in the MS with behavioral data showing an increase in 
hippocampal dependent processes, providing further evidence for a relationship between the 
cholinergic system and hippocampus. Since nAChRs are located both pre- and 
postsynaptically in the hippocampus and perirhinal cortex, they are thought to play a 
significant role in modifying synaptic plasticity, making it possible that these nicotine 
facilitated increases in neuronal activation and novel object recognition processes were a 
result of nAChR facilitated LTP (Gould, 2008).  
Research Implications 
The study of nicotine-facilitated memory enhancements extends far beyond the realm 
of behavioral studies in rats. For example, there is a large amount of research regarding the 
role of cholinergic system in Alzheimer’s disease. As previously mentioned, cholinergic 
dysfunction is one of the hallmarks of AD.  
Several transgenic animal models have been created to mimic the amyloid-driven 
neurodegeneration seen in humans. The Tg2576 mouse was one of the first transgenic mice 
models to express human APP (hAPP) and develop amyloid plaques. It has been repeatedly 
shown that Tg2576 mice have severe deficits in spatial memory as assessed by the MWM 
(Arendash, 2002). APP23 mice, like Tg2476 mice, express hAPP and display the 
histopathological and behavioral hallmarks of AD. Furthermore, APP23 mice display 
neuronal loss in the cholinergic system, making them useful for understanding the behavioral 
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manifestations of cholinergic dysfunction in AD. Like the Tg2476 mice, APP23 mice show 
deficits in spatial memory as assessed by the MWM (Kobayashi, 2005). These strains have 
also been examined using NOR tests. Studies reveal that both APP23 and Tg2476 transgenic 
mice display deficits in object recognition as assessed by the NOR test (Bruin, 2006 & 
Taglialatela, 2009) 
While the first drugs approved to treat AD acted by inhibiting the degradation of 
ACh, the most recently approved therapeutic drug for the treatment of AD, galantamine 
(marketed as Nivalin), is an allosteric modulator of the α-subunit of nAChRs. By 
allosterically binding to the α-subunit, galantamine is able to enhance nAChR activity by 
increasing their sensitivity to endogenous ligands (Schroeder, 1994). Activation of α7-
nAChRs has been shown to protect against glutamate-induced apoptosis, a common cause of 
neurodegeneration in AD (Takada, 2003). Furthermore, acute administration of galantamine 
causes an increase in neurotrophic growth factors such as insulin-like growth factor 2 in the 
mouse hippocampus. These effects were not seen when co-administered with 
methyllycaconitine, a selective α7-nAChR antagonist, suggesting the increase insulin-like 
growth factor 2 was caused by α7-nAChR activation (Kita, 2012). 
Behavioral techniques have also been used to demonstrate the effects of galantamine 
on spatial memory formation in rats. For example, galantamine has been shown to attenuate 
scopolamine-induced deficits of spatial memory acquisition in rats, as assessed by both the 
MWM and T-Maze (Fishkin, 1993). Bruin and colleagues also demonstrated that 10mg/kg of 
galantamine reversed the effects of scopolamine induced cognitive deficits in a modified 
version of the NOR test (Bruin, 2006). Furthermore, galantamine administration has been 
show to improve MWM performance in APP23 mice (Van Dam, 2003 & Van Dam 2007). 
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The use of muscarinic agonists in AD treatment has also been extensively studied. As 
previously mentioned, one of the hallmarks of AD is the formation of amyloid plaques, 
which are composed of insoluble Aβ aggregates. These Aβ proteins are a produced by the 
proteolytic processing of the amyloid precursor protein (APP) by α, β, and γ-secretases. 
There are two possible outcomes of APP processing: if APP is first cleaved by β-secretase 
and then by γ-secretase, Aβ is produced. However, if APP is first cleaved by α-secretas, β-
secretase is unable to cleave and no Aβ is produced. Therefore, inducing proteolytic 
processing by α-secretase provides a possible mechanism for inhibiting amyloid plaque 
formation. Several studies have shown that administration of M1 and M3 muscarinic agonists 
can decrease Aβ production (Esler, 2001). These effects are thought to be mediated by a 
variety of cell signaling processes such as activation of the protein kinase C (PKC) and 
mitogen-activated protein kinase (MAPK) dependent pathways. Activation of these pathways 
ultimately results in increased α-secretase production, thereby causing a decrease in Aβ 
production (Haring, 1998). Interestingly, M2 and M4 receptor activation does not cause an 
increase in α-secretase production. M2 activation may even decrease α-secretase release. 
nAChR activation may also stimulate the production of α-secretase, making both nAChR and 
mAChR stimulation potentially useful for AD treatment (Fisher, 2008). 
There are several studies that investigate nicotine’s potential to act as a therapeutic 
AD drug. The two forms of Aβ, Aβ40 and Aβ42, are synthesized in healthy individuals. In 
AD there is a marketed increase in Aβ42 production that presents a problem; while Aβ40 is 
easily digested within the cell, the more hydrophobic Aβ42 is not, allowing it to be present 
for longer periods of time and aggregate into amyloid plaques. Aβ42 exist in an equilibrium 
of conformational states, folding into either α-helical monomers or β-sheet structures. The β-
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sheet structures have a high propensity to aggregate into amyloid plaques, while the α-helical 
monomers are not thought to cause neurotoxic effects. Nicotine administration has been 
shown to inhibit the formation of amyloid plaques from β-sheet structures in vitro. While the 
exact mechanism by which this occurs is not fully understood, it is thought to be a result of 
nicotine binding to β-sheet structures and inhibiting aggregation (Zeng, 2001). There is also 
substantial evidence that several complex molecules help bind metals such as Cu2+, Fe2+, 
and Zn2+ to Aβ42. This metal binding induces it to assume the β-sheet conformation. 
Research shows that nicotine administration is able to stabilize metal ion homeostasis, 
decreasing the amount of ions available for Aβ42 binding, effectively lowering the amount of 
Aβ42 in the β-sheet conformation (Zhang, 2006). 
The cholinergic system is an unbelievably complex system, and the brain areas that it 
influences are quite widespread. There is still a large amount of research that needs to be 
conducted in order to fully understand all of its responsibilities. As I have shown in the pages 
above, nicotine is able to stimulate the cholinergic system and enhance memory acquisition 
processes. So while nicotine often gets a bad reputation due to its addictive qualities, it may 
one day offer significant therapeutic benefits. 
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